Musk odorant
Novel alicyclic compounds with an unsaturated five-membered ring structure address the weakness of existing musk fragrances, offering a strong and persistent musk fragrance with fruity notes.
Patent Information
- Application Number
- CN202380036642.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-04-29
- Filing Date
- 2023-04-28
- Publication Date
- 2024-12-06
AI Technical Summary
Existing alicyclic musk compounds in perfumery lack strength and tenacity, failing to provide a strong and substantive musk fragrance.
Development of novel alicyclic compounds with an unsaturated five-membered ring structure, such as 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl propionate, which impart a musk fragrance with improved persistence and fruity notes.
The compounds offer a strong musky odor with red fruit nuances, providing a more powerful and attractive fragrance compared to existing compounds.
Smart Images

Figure BDA0005102794440000021 
Figure BDA0005102794440000022 
Figure BDA0005102794440000031
Abstract
Description
Technical Field
[0001] The present invention relates to the field of perfumery. More specifically, it relates to compounds of formula (I) as defined below and their use as perfuming ingredients. Therefore, according to the present invention, the present invention includes compounds of the present invention as part of a perfuming composition or a perfuming consumer product. Background Art
[0002] Ingredients that impart musk notes are very popular and widely used in perfumery as they are considered one of the key perfumery base notes. Since the introduction of 2-[1-(3,3-dimethyl-1-cyclohexen-1-yl)ethoxy]-2-methylpropyl propionate, there has been an increasing interest in this class of alicyclic compounds with a musky odor and accompanying fruity and amber notes. In the prior art, 3,3-dimethylcyclopentyl analogs are described as being weak and lacking tenacity. In US2006046955, unsaturated 6-membered ring analogs are reported. However, these compounds, particularly 2-[1-(3,3-dimethyl-1-cyclohexen-1-yl)ethoxy]-2-methylpropyl propionate, are not as strong as
[0003] Therefore, there is still a need to develop an alicyclic musk compound that can impart a strong and substantive musk fragrance.
[0004] The present invention provides a novel alicyclic perfumery ingredient of formula (I) containing an unsaturated five-membered ring, which has never been reported before and which imparts a musk fragrance while maintaining the same Similar good persistence. The prior art documents mentioned above do not disclose compounds of formula (I) nor the organoleptic properties of compounds of formula (I). Summary of the invention
[0005] Surprisingly, it has now been found that compounds of formula (I) have a strong musky odor which is particularly popular in perfumery.
[0006] The first object of the present invention is a compound of formula (I)
[0007]
[0008] The compound is in the form of any stereoisomer or a mixture thereof, wherein one dotted line represents a carbon-carbon double bond and the other dotted line represents a carbon-carbon single bond; n is 0 or 1; X is a C(=O) or C(Me)2 group; R is a hydrogen atom, C 1-6 Alkyl, C 1-6 Alkoxy, C 2-6 Alkenyl, C2-6 Alkynyl or C 3-6 Cycloalkyl, C(═O)R′ group or CH(OR″)R″ group, wherein R′ is C 1-3 Alkyl or C 1-3 Alkoxy, and R" are each independently a hydrogen atom or a C 1-3 alkyl.
[0009] The compounds are useful as perfuming ingredients, for example imparting odor notes of the musk type with red fruit nuances.
[0010] For the sake of clarity, by expressing "any stereoisomer thereof or mixture thereof" or similar expressions, it is meant the normal meaning understood by those skilled in the art, that is, the compound of formula (I) can be a pure enantiomer or diastereomer. In other words, the compound of formula (I) can have multiple stereo centers, and each of the stereo centers can have two different stereochemicals (e.g., R or S). The compound of formula (I) can even be in the form of a pure enantiomer, or in the form of a mixture of multiple enantiomers or diastereomers. The compound of formula (I) can be a racemic form or a non-racemic (scalemic) form. Therefore, the compound of formula (I) can be a stereoisomer, or in the form of a material composition comprising or consisting of various stereoisomers.
[0011] For the sake of clarity, by stating "wherein one dotted line represents a carbon-carbon double bond and the other dotted line represents a carbon-carbon single bond" or similar statements, it is meant the normal meaning understood by a person skilled in the art, i.e. the entire bond (solid and dotted) between the carbon atoms connected by the dotted lines is a carbon-carbon single bond or a double bond. In other words, the compound of formula (I) contains a cyclopentenyl group and may be of the following formula:
[0012]
[0013] The compound is in the form of any one of its stereoisomers or a mixture thereof, wherein X, n and R have the same meanings as defined above.
[0014] According to any embodiment of the present invention, the compounds of the present invention may be in the form of a material composition comprising compounds of formula (Ia) and formula (Ib). More specifically, the material composition may comprise 20 to 90% w / w of the compound of formula (Ia) and 5 to 50% w / w of the compound of formula (Ib), the percentages being by weight relative to the total weight of the material composition.
[0015] The terms "alkyl", "alkoxy", "alkenyl" and "alkynyl" are understood to include branched and straight chain alkyl, alkoxy, alkenyl and alkynyl groups. The term "alkenyl" is understood to include an olefinic double bond. The term "alkynyl" is understood to include a triple bond. The term "cycloalkyl" is understood to include monocyclic groups.
[0016] According to any of the above embodiments of the present invention, the compound (I) is C 12 ~C 20 Compound, preferably C 14 ~C 27 Compound.
[0017] According to a particular embodiment, when X is C(═O), then n is 0.
[0018] According to a specific embodiment, when n is 0, R can be C 1-6 Alkoxy, especially C 1-3 Alkoxy, especially C 1-2 Alkoxy, even more particularly ethoxy.
[0019] According to any of the above embodiments of the present invention, n may be 1.
[0020] According to any of the above embodiments of the present invention, X may be a C(Me)2 group.
[0021] According to any of the above embodiments of the present invention, the compound of formula (I) is a compound of formula (II),
[0022]
[0023] The compound is in the form of any one of its stereoisomers or a mixture thereof, wherein the dashed line and R have the same meanings as defined above.
[0024] According to any of the above embodiments of the present invention, R can be a hydrogen atom, C 1-4 Alkyl, C 1-4 Alkoxy, C 2-4 Alkenyl, C 2-4 Alkynyl or C 3-6 a cycloalkyl group, a C(═O)R′ group or a CH(OR″)R″ group, wherein R′ is C 1-3 Alkyl or C 1-3 Alkoxy, and R" are each independently a hydrogen atom or a C 1-3 In particular, R can be a hydrogen atom, a C 1-3 Alkyl, C 1-3 Alkoxy, C 2-3 Alkenyl, C 2-3 Alkynyl or C 3-6Cycloalkyl, C(═O)R′ group or CH(OR″)R″ group, wherein R′ is C 1-2 Alkyl or C 1-2 Alkoxy, and R" are each independently a hydrogen atom or a C 1-2 In particular, R can be a hydrogen atom, a C 1-3 Alkyl, C 1-3 Alkoxy, C 2-3 Alkenyl, C 2-3 Alkynyl or C 3-6 a cycloalkyl group, a CH(OH)Me group, a CH2OH group, or a C(=O)R' group, wherein R' is C 1-2 Alkyl or C 1-2 In particular, R can be C 1-3 Alkyl, C 1-3 Alkoxy, C 2-3 Alkenyl, C 2-3 Alkynyl or C3 cycloalkyl or C(=O)R' group, wherein R' is C 1-2 Alkyl. In particular, R may be ethyl, propyl, ethoxy, prop-1-en-1-yl, 2-ethynyl or cyclopropyl or a C(═O)Me group. In particular, R may be ethyl, ethoxy or prop-1-en-1-yl. Even more particularly, R may be ethyl.
[0025] According to any of the above embodiments of the present invention, the compound of formula (I) is a compound of formula (III),
[0026]
[0027] The compound is in the form of any one of its stereoisomers or a mixture thereof.
[0028] As a specific example of the compounds of the present invention, there can be cited, for example, a composition of matter comprising 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl propionate and 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl propionate in a ratio of 80:20, which imparts a musky note combined with a red fruit note, in particular a raspberry note. The composition of matter of the invention also has a cooked apple note of delta-damascenone. The composition of matter of the invention has a rich top and middle note while maintaining a high affinity, and can be used with Comparable.
[0029] As another example, there can be cited 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl propionate, which has an odor similar to that mentioned above.
[0030] As other specific but non-limiting examples of the compounds of the present invention, the compounds in the following Table 1 can be cited.
[0031] Table 1: Inventive compounds and comparative compounds and their odor characteristics
[0032]
[0033]
[0034]
[0035] For the sake of clarity, by the wavy bond in the compounds in the above table, i.e., the composition of matter comprising 2-butenoic acid 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ester and 2-butenoic acid 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ester or the like, it is meant the normal meaning understood by a person skilled in the art, i.e., the double bond may have a cis configuration corresponding to the Z isomer, a trans configuration corresponding to the E isomer, or a mixture thereof. In other words, the compound may be in the form of its E or Z isomer or in the form of a mixture thereof, for example, the process of the present invention results in a composition of matter consisting of one or more of the compounds having the same chemical structure but different double bond configurations.
[0036] The compounds of the present invention are surprisingly very powerful. All the comparative compounds listed below are close to the compounds of the present invention in structure, but the odor notes they impart are less attractive and weaker. Only the compounds of the present invention impart a strong and intimate fragrance.
[0037] According to a specific embodiment of the present invention, the compound of formula (I) is 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl propionate, 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl propionate or a mixture thereof; 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-oxoethyl propionate, 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-oxoethyl propionate or a mixture thereof; 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl cyclopropanecarboxylate, 2-[1 -(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ester or a mixture thereof; 1-(3,3-dimethyl-1-cyclopenten-1-yl)ethyl malonate, 1-(4,4-dimethyl-1-cyclopenten-1-yl)ethyl malonate or a mixture thereof; 2-butenoic acid 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ester, 2-butenoic acid 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ester or a mixture thereof; 2-hydroxypropionic acid 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ester, 2-hydroxypropionic acid 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ester or a mixture thereof; 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ethyl carbonate, 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ethyl carbonate or a mixture thereof; 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl methoxyacetate, 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl methoxyacetate or a mixture thereof; 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl 2-oxopropanoate 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl 2-oxopropanoate or a mixture thereof; 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl oxalate, 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl oxalate or a mixture thereof; 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl propiolate, 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl propiolate or a mixture thereof;2-Butynoic acid 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ester, 2-butynoic acid 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ester or a mixture thereof; 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl acrylate, 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl acrylate or a mixture thereof; 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl butyrate, 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl butyrate or a mixture thereof. In particular, the compound of formula (I) can be selected from the group consisting of: 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl propionate, 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl propionate or a mixture thereof; 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl cyclopropanecarboxylate, cyclopropane 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl formate or a mixture thereof; 1-(3,3-dimethyl-1-cyclopenten-1-yl)ethyl malonate, 1-(4,4-dimethyl-1-cyclopenten-1-yl)ethyl malonate or a mixture thereof; 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl 2-butenoate, 2-butenoic acid 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ester or a mixture thereof; 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl carbonate, 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl carbonate or a mixture thereof; 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ethyl carbonate or a mixture thereof; 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ethyl carbonate 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl 2-oxopropanoate or a mixture thereof; 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl propiolate, 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl propiolate or a mixture thereof;Butyric acid 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ester, butyric acid 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ester or a mixture thereof. Even more particularly, the compound of formula (I) is a material composition comprising propionic acid 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ester and propionic acid 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ester. ;
[0038] When the odor of the compounds of the present invention is compared to the odor of the prior art compound 2-[1-(3,3-dimethyl-1-cyclohexen-1-yl)ethoxy]-2-methylpropyl propionate, the compounds of the present invention are distinguished by having significantly stronger musk-like notes combined with raspberry notes and lacking the powdery notes characteristic of the prior art compound. In addition, the compounds of the present invention impart a A similar, noticeably stronger, more approachable note.
[0039] The odor of the compounds of the present invention is also different from that of the prior art compounds by lacking or not having obvious animal and ambrette notes, which are characteristic of the prior art compounds. Such differences make the compounds of the present invention and the prior art compounds each suitable for different uses, i.e., imparting different sensory impressions.
[0040] As mentioned above, the present invention relates to the use of compounds of formula (I) as perfuming ingredients. In other words, the present invention relates to a method or process for imparting, enhancing, improving or modifying the odor characteristics of a perfuming composition or a perfumed article or surface, which method comprises adding to said composition or article an effective amount of at least one compound of formula (I), for example to impart a typical fragrance note thereto. It will be understood that the final hedonic effect may depend on the precise dosage and the organoleptic properties of the compounds of the present invention, but in any case, the addition of the compounds of the present invention will impart a typical style in the form of a note, touch or subtle feature (aspect) to the final product, depending on the dosage.
[0041] By "use of a compound of formula (I)" one must here also understand the use of any composition which comprises a compound of formula (I) and which can be advantageously used in the perfumery industry.
[0042] Said compositions, which in fact can advantageously be used as perfuming ingredients, are also an object of the present invention.
[0043] Therefore, another object of the present invention is a perfuming composition comprising:
[0044] i) at least one inventive compound as defined above as perfuming ingredient;
[0045] ii) at least one ingredient selected from the group consisting of a fragrance carrier and a fragrance base; and
[0046] iii) optionally, at least one flavor adjuvant.
[0047] By "perfume carrier" it is meant here a material which is practically neutral from a perfume point of view, ie which does not significantly alter the organoleptic properties of the perfuming ingredient. The carrier may be liquid or solid.
[0048] As liquid carrier, one may cite, as non-limiting examples, an emulsifying system, i.e. a solvent and a surfactant system, or a solvent commonly used in the perfume industry. A detailed description of the nature and types of solvents commonly used in the perfume industry is not exhaustive. However, one may cite, as non-limiting examples, solvents such as butylene glycol or propylene glycol, glycerol, dipropylene glycol and its monoethers, 1,2,3-propanetriol triacetate, dimethyl glutarate, dimethyl adipate, 1,3-diacetoxyprop-2-yl acetate, diethyl phthalate, isopropyl myristate, (rosin resin, available from Eastman), benzyl benzoate, benzyl alcohol, 2-(2-ethoxyethoxy)-1-ethanol, triethyl citrate or mixtures thereof, which are most commonly used. Or solvents of natural origin such as glycerol or various vegetable oils such as palm oil, sunflower oil or linseed oil. For compositions containing both a fragrance carrier and a fragrance base, in addition to those specified above, other suitable fragrance carriers may also be ethanol, water / ethanol mixtures, limonene or other terpenes, isoparaffins, such as those sold under the trademark Those known (source: Exxon Chemical), or glycol ethers and glycol ether esters, such as those sold under the trademark Those known as (source: Dow Chemical Company), or hydrogenated castor oil, such as those sold under the trademark RH 40 Those known per se (source: BASF).
[0049] Solid carrier refers to a kind of material, and some composition of perfuming composition or perfuming composition can be combined with it chemically or physically.Generally speaking, this type of solid carrier is used for stabilizing composition, or controls the evaporation rate of composition or some composition.Solid carrier is what is used in this field at present, and those skilled in the art know how to reach the desired effect.Yet, as the non-limiting example of solid carrier, absorbent glue or polymer or inorganic material can be enumerated, for example porous polymer, cyclodextrin, dextrin, maltodextrin, wood-based material, organic or inorganic gel, clay, gypsum, talcum or zeolite.
[0050] As other non-limiting examples of solid carriers, encapsulating materials can be cited. Examples of such materials may include wall-forming materials and plasticizers, such as glucose syrup, natural or modified starch, hydrocolloids, cellulose derivatives, polyvinyl acetate, polyvinyl alcohol, proteins or pectins, plant gums such as acacia gum (gum arabic), urea, sodium chloride, sodium sulfate, zeolite, sodium carbonate, sodium bicarbonate, clay, talc, calcium carbonate, magnesium sulfate, gypsum, calcium sulfate, magnesium oxide, zinc oxide, titanium dioxide, calcium chloride, potassium chloride, magnesium chloride, zinc chloride, carbohydrates, sugars such as sucrose, monosaccharides, disaccharides, trisaccharides and polysaccharides and derivatives such as chitosan, starch, cellulose, carboxymethyl methylcellulose, methylcellulose, hydroxyethyl cellulose, ethyl cellulose, propyl cellulose, polyols / sugar alcohols Such as sorbitol, maltitol, xylitol, erythritol and isomalt, polyethylene glycol (PEG), polyvinyl pyrrolidone (PVP), polyvinyl alcohol, acrylamide, acrylates, polyacrylic acid and related substances, maleic anhydride copolymers, amine-functional polymers, vinyl ethers, styrene, polystyrene sulfonates, vinyl acid, ethylene glycol-propylene glycol block copolymers, vegetable gums, acacia gum, pectin, xanthan gum, alginates, carrageenan, citric acid or any water-soluble solid acid, fatty alcohol or fatty acid and mixtures thereof, or in references such as H. Scherz, Hydrokolloide: Stabilisatoren, Dickungs- und Geliermittel in Lebensmitteln, Band 2 der Schriftenreihe Lebensmittelchemie, Materials listed in Behr's Verlag GmbH & Co., Hamburg, 1996. Encapsulation is a process well known to the person skilled in the art and may be performed, for example, using techniques such as spray drying, agglomeration or extrusion; or consist of coating encapsulation including coacervation and complex coacervation techniques.
[0051] As non-limiting examples of solid supports, one may in particular cite core-shell capsules using resins of the aminoplast, polyamide, polyester, polyurea or polyurethane type or mixtures thereof (all said resins being well known to a person skilled in the art), by a phase separation process initiated using techniques such as polymerization, interfacial polymerization, coacervation or these techniques together (all said techniques having been described in the prior art), and optionally in the presence of polymeric stabilizers or cationic copolymers.
[0052] The resins may be produced by polycondensation of aldehydes such as formaldehyde, 2,2-dimethoxyacetaldehyde, glyoxal, glyoxylic acid or glycolaldehyde and mixtures thereof with amines such as urea, benzoguanamine, glycoluril, melamine, methylolmelamine, methylated methylolmelamine, guanazole, and the like and mixtures thereof. Alternatively, preformed resins may be used, such as those sold under the trademark (Source: Cytec Technology Corp.), (Source: Cytec TechnologyCorp.), or (Source: BASF) Those that are commercially available.
[0053] Other resins are obtained by mixing a polyol such as glycerol with a polyisocyanate such as a trimer of hexamethylene diisocyanate, a trimer of isophorone diisocyanate or xylylene diisocyanate, or a biuret of hexamethylene diisocyanate, or a trimer of xylylene diisocyanate and trimethylolpropane (known under the trade name Known sources: those produced by polycondensation of Mitsui Chemicals), of which the trimer of xylylene diisocyanate with trimethylolpropane and the biuret of hexamethylene diisocyanate are preferred.
[0054] Some research literature related to the encapsulation of spices by condensation of amino resins, i.e. melamine-based resins, with aldehydes includes articles such as Acta Polymerica, 1989, vol. 40, pages 243, 325 and 683 and 1990, vol. 41, page 91, published by K. Dietrich et al. These articles have described various parameters that affect the preparation of such core-shell microcapsules according to prior art methods, which are also further detailed and exemplified in patent literature. US4'396'670 of Wiggins Teape Group Limited is a relevant early example of the latter. Since then, many other authors have enriched the literature in this field, and it is not possible to cover all published progress here, but general knowledge of encapsulation technology is very important. More recent targeted publications also involve suitable uses of such microcapsules, representative articles such as K. Bruyninckx and M. Dusselier, ACS Sustainable Chemistry & Engineering, 2019, vol. 7, pages 8041-8054.
[0055] By "perfume base" it is meant here a composition comprising at least one perfuming co-ingredient.
[0056] The perfuming co-ingredient does not conform to formula (I). Furthermore, by "perfuming co-ingredient" it is meant here a compound which is used in a perfuming preparation or composition to impart a hedonic effect; that is, primarily for imparting or regulating an odour. In other words, to be considered a perfuming co-ingredient such a co-ingredient must be recognized by a person skilled in the art as being able to impart or modify the odour of a composition in an active or pleasant manner, rather than merely having an odour. In addition to modifying or imparting an odour, a perfuming co-ingredient may impart additional benefits, such as persistence, burst, malodour counteracting, antimicrobial action, antiviral action, microbial stability or pest control.
[0057] The nature and types of perfuming co-ingredients present in the base do not warrant a more detailed description here, which is in no way exhaustive, and a person skilled in the art will be able to choose them according to his general knowledge and according to the intended use or application and the desired organoleptic effect. In general, these perfuming co-ingredients belong to different chemical classes, such as alcohols, lactones, aldehydes, ketones, esters, ethers, acetates, nitriles, terpenoids, nitrogen- or sulfur-containing heterocyclic compounds and essential oils, and may be of natural or synthetic origin.
[0058] In particular, one may cite the perfuming auxiliary ingredients usually used in perfume formulations, for example:
[0059] - Aldehyde aroma components: decanal, dodecanal, 2-methylundecane, 10-undecenal, octanal, nonanal and / or nonenal;
[0060] - Aromatic herbal ingredients: eucalyptus oil, camphor, eucalyptol, 5-methyltricyclo[6.2.1.0-2,7-]undec-4-one, 1-methoxy-3-hexanethiol, 2-ethyl-4,4-dimethyl-1,3-oxathiane, 2,2,7 / 8,9 / 10-tetramethylspiro[5.5]undec-8-en-1-one, menthol and / or α-pinene;
[0061] - balsamic ingredients: coumarin, ethyl vanillin and / or vanillin;
[0062] - Citrus aroma ingredients: dihydromyrcenol, citral, orange oil, linalyl acetate, citronellyl nitrile, orange terpenes, limonene, 1-p-menthen-8-yl acetate and / or 1,4(8)-p-menthenadiene;
[0063] -Floral fragrance ingredients: methyl dihydrojasmonate, linalool, citronellol, phenylethyl alcohol, 3-(4-tert-butylphenyl)-2-methylpropanal, hexyl cinnamaldehyde, benzyl acetate, benzyl salicylate, tetrahydro-2-isobutyl-4-methyl-4(2H)-pyranol, β-ionone (β-violet ketone), methyl 2-(methylamino)benzoate, (E)-3-methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one, (1E)-1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-1-penten-3-one 1-(2,6,6-trimethyl-1,3-cyclohexadien-1-yl)-2-butene-1-one, (2E)-1-(2,6,6-trimethyl-2-cyclohexene-1-yl)-2-butene-1-one, (2E)-1-[2,6,6-trimethyl-3-cyclohexene-1-yl]-2-butene-1-one, (2E)-1-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2-butene-1-one, 2,5-dimethyl-2-indanemethanol, 2,6,6-trimethyl-3-cyclohexene-1-carboxylate, 3-(4 ,4-dimethyl-1-cyclohexen-1-yl propanal, 3-(3,3 / 1,1-dimethyl-5-indanyl) propanal, hexyl salicylate, 3,7-dimethyl-1,6-nonadien-3-ol, 3-(4-isopropylphenyl)-2-methyl propanal, tricyclodecenyl acetate, geraniol, p-menth-1-en-8-ol, 4-(1,1-dimethylethyl)-1-cyclohexyl acetate, 1,1-dimethyl-2-phenylethyl acetate, 4-cyclohexyl-2-methyl-2-butanol, amyl salicylate, methyl dihydrojasmonate, 3-methyl-5-phenyl 1-Hydroxy-1-pentanol, tricyclodecenyl propionate, geranyl acetate, tetrahydrolinalool, cis-7-p-menthol, (S)-2-(1,1-dimethylpropoxy)propyl propionate, 2-methoxynaphthalene, 2,2,2-trichloro-1-phenylethyl acetate, 4 / 3-(4-hydroxy-4-methylpentyl)-3-cyclohexene-1-carbaldehyde, amylcinnamaldehyde, 8-decene-5-lactone, 4-phenyl-2-butanone, isononyl acetate, 4-(1,1-dimethylethyl)-1-cyclohexyl acetate, tricyclodecenyl isobutyrate, and / or a mixture of methylionone isomers;
[0064] - Fruity aroma ingredients: γ-undecalactone, 2,2,5-trimethyl-5-pentylcyclopentanone, 2-methyl-4-propyl-1,3-oxathiacyclopentane, 4-decanoic acid, ethyl 2-methyl-valerate, hexyl acetate, ethyl 2-methylbutyrate, γ-nonalactone, allyl heptanoate, 2-phenoxyethyl isobutyrate, ethyl 2-methyl-1,3-dioxolane-2-acetate, diethyl 1,4-cyclohexanedicarboxylate, 3-methyl-2-hexen-1-yl acetate, 1-[3,3-dimethylcyclohexyl]ethyl [3-ethyl-2-oxiranyl] acetate and / or diethyl 1,4-cyclohexanedicarboxylate;
[0065] - Green fragrance ingredients: 2-methyl-3-hexanone (E)-oxime, 2,4-dimethyl-3-cyclohexene-1-carbaldehyde, 2-tert-butyl-1-cyclohexyl acetate, styryl acetate, (2-methylbutoxy) allyl acetate, 4-methyl-3-decen-5-ol, diphenyl ether, (Z)-3-hexen-1-ol and / or 1-(5,5-dimethyl-1-cyclohexen-1-yl)-4-penten-1-one;
[0066] - Musk ingredients: 1,4-dioxa-5,17-cycloheptadecanedione, (Z)-4-cyclopentadecen-1-one, 3-methylcyclopentadecen-1-one, 1-oxa-12-cyclohexadecene-2-one, 1-oxa-13-cyclohexadecene-2-one, (9Z)-9-cycloheptadecene-1-one, 2-{1S)-1-[(1R)-3,3-dimethylcyclohexyl]ethoxy}-2-oxoethyl propionate, 3-methyl-5-cyclohexane Pentadecene-1-one, 4,6,6,7,8,8-hexamethyl-1,3,4,6,7,8-hexahydrocyclopenta[G]-2-benzopyran, (1S,1'R)-2-[1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy]-2-methylpropyl propionate, oxacyclohexadecane-2-one and / or (1S,1'R)-[1-(3',3'-dimethyl-1'-cyclohexyl)ethoxycarbonyl]methyl propionate;
[0067] - Woody components: 1-[(1RS,6SR)-2,2,6-trimethylcyclohexyl]-3-hexanol, 3,3-dimethyl-5-[(1R)-2,2,3-trimethyl-3-cyclopenten-1-yl]-4-penten-2-ol, 3,4'-dimethylspiro[2,9'-tricyclo[6.2.1.0 2,7 ] undec[4]ene, (1-ethoxyethoxy)cyclododecane, 2,2,9,11-tetramethylspiro[5.5]undec-8-en-1-yl acetate, 1-(octahydro-2,3,8,8-tetramethyl-2-naphthyl)-1-ethanone, patchouli oil, terpene fraction of patchouli oil, (Source: Firmenich SA), (1'R,E)-2-ethyl-4-(2',2',3'-trimethyl-3'-cyclopenten-1'-yl)-2-buten-1-ol, 2-ethyl-4-(2,2,3-trimethyl-3-cyclopenten-1-yl)-2-buten-1-ol, methyl cedryl ketone, 5-(2,2,3-trimethyl-3-cyclopentenyl)-3-methylpentan-2-ol, 1-(2,3,8,8-tetramethyl-1,2,3,4,6,7,8,8a-octahydronaphthalen-2-yl)ethan-1-one and / or isobornyl acetate;
[0068] -Other ingredients (e.g. amber, powdery, spicy or watery): dodecahydro-3a,6,6,9a-tetramethyl-naphtho[2,1-b]furan and any of its stereoisomers, piperonal, anisaldehyde, eugenol, cinnamaldehyde, clove oil, 3-(1,3-benzodioxol-5-yl)-2-methylpropanal, 7-methyl-2H-1,5-benzodioxepin-3(4H)-one, 2,5,5-trimethyl-1,2,3,4,4a,5,6,7-octahydro-2-naphthol, 1-phenylvinyl acetate, 6-methyl-7-oxa-1-thia-4-azaspiro[4.4]nonane and / or 3-(3-isopropyl-1-phenyl)butanal.
[0069] The perfume base according to the invention may not be limited to the above-mentioned perfuming co-ingredients, and many other such co-ingredients are anyway listed in references such as S. Arctander, Perfume and Flavor Chemicals, 1969, Montclair, New Jersey, USA or its updated editions, or other works of similar nature, as well as a large number of patent documents in the field of perfumery. It should also be understood that the co-ingredients may also be compounds known to release various types of perfuming compounds in a controlled manner, also known as properfumes or profragrances. Non-limiting examples of suitable pro-fragrances may include 4-(dodecylthio)-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-2-butanone, 4-(dodecylthio)-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-butanone, trans-3-(dodecylthio)-1-(2,6,6-trimethyl-3-cyclohexen-1-yl)-1-butanone, 3-(dodecylsulfonyl)-1-(2,6,6-trimethylcyclohex-3-en-1-yl)butan-1-one , linear polysiloxane copolymer of (3-mercaptopropyl)(methyl)dimethoxysilane, 2-(dodecylthio)octane-4-one, 2-(dodecylsulfonyl)octane-4-one, 4-oxooctane-2-yl dodecanoate, 2-phenylethyl oxy(phenyl)acetate, 3,7-dimethyloctane-2,6-dien-1-yl oxy(phenyl)acetate, (Z)-hex-3-en-1-yl oxy(phenyl)acetate, 3,7-dimethyl-2,6-octadien-1-yl hexadecanoate, bis(3,7 -dimethyl oct-2,6-dien-1-yl) ester, hexadecanoic acid (2E,6Z)-2,6-nonadien-1-yl ester, tetradecanoic acid (2E,6Z)-2,6-nonadien-1-yl ester, dodecanoic acid (2E,6Z)-2,6-nonadien-1-yl ester, (2-((2-methylundec-1-en-1-yl)oxy)ethyl)benzene, 1-methoxy-4-(3-methyl-4-phenethoxybut-3-en-1-yl)benzene, (3-methyl-4-phenethoxybut-3-en-1-yl)benzene, 1-(( 1-((2-methylundec-1-en-1-yl)oxy)-2-methylundec-1-ene, (2-((2-methylundec-1-en-1-yl)oxy)ethoxy)benzene, 2-methyl-1-(octan-3-yloxy)undec-1-ene, 1-methoxy-4-(1-phenylethoxyprop-1-en-2-yl)benzene, 1-methyl-4-(1-phenylethoxyprop-1-en-2-yl)benzene, 2-(1-phenylethoxyprop-1-en-2-yl)naphthalene, (2-phenylethoxyvinyl)benzene, 2-(1-((3,7-dimethyloct-6-en-1-yl)oxy)prop-1-en-2-yl)naphthalene, (2-((2-pentylcyclopentylidene)methoxy)ethyl)benzene, 4-allyl-2-methoxy-1-((2-methoxy-2-phenylvinyl)oxy)benzene, (2-((2-heptylcyclopentylidene))methoxy)ethyl)benzene, 1-methoxy-4-(1-phenylethoxyprop-1-en-2-yl)benzene, (2-((2-methyl-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-1-en-1-yl)oxy)ethyl)benzene, 1-methoxy-4-(2-methyl-3-phenylethoxyallyl)benzene, (2-((2- benzene, 1-isopropyl-4-methyl-2-((2-pentylcyclopentylidene)methoxy)benzene, 2-methoxy-1-((2-pentylcyclopentylidene)methoxy)-4-propylbenzene, 2-ethoxy-1-((2-methoxy-2-phenylvinyl)oxy)-4-methylbenzene, 3-methoxy-4-((2-methoxy-2-phenylvinyl)oxy)benzaldehyde, 1-isopropyl-2-((2-methoxy)-2-phenylvinyl)oxy)-4-methylbenzene, 4-((2-(hexyloxy)-2-phenylvinyl)oxy)-3-methoxybenzaldehyde or a mixture thereof.
[0070] By "perfume adjuvant" it is meant here ingredients capable of imparting additional additional benefits, such as colour, specific lightfastness, chemical stability, etc. A detailed description of the nature and types of adjuvants commonly used in perfuming compositions cannot be exhaustive, but it must be mentioned that said ingredients are well known to the person skilled in the art. The following may be cited as specific non-limiting examples: viscosity agents (e.g. surfactants, thickeners, gelling agents and / or rheology modifiers), stabilizers (e.g. preservatives, antioxidants, heat / light and / or buffers or chelating agents, such as BHT), colorants (e.g. dyes and / or pigments), preservatives (e.g. antibacterial or antimicrobial or antifungal or anti-irritants), abrasives, skin cooling agents, fixatives, insect repellents, ointments, vitamins and mixtures thereof. A "fixative", also called a "modifier", is understood here as an agent having the ability to influence the way in which an observer or user perceives the odour of a composition into which it is incorporated, in particular the rate of evaporation and the intensity, over time, compared to the same perception without the modifier. In particular, the conditioning agent allows to prolong the time of perceiving its fragrance. Non-limiting examples of suitable conditioning agents may include methyl glucoside polyol; ethyl glucoside polyol; propyl glucoside polyol; isocetyl alcohol; PPG-3 myristyl ether; neopentyl glycol di(ethylhexanoate); sucrose laurate; sucrose dilaurate, sucrose myristate, sucrose palmitate, sucrose stearate, sucrose distearate, sucrose tristearate, hyaluronic acid disaccharide sodium salt, sodium hyaluronate, propylene glycol propyl ether; dicetyl ether; polyglyceryl-4 ether; isoceteth-5; isocetyl Isoceteth-7, Isoceteth-10; Isoceteth-12; Isoceteth-15; Isoceteth-20; Isoceteth-25; Isoceteth-30; Disodium Lauroamphodipropionate; Hexaethylene Glycol Monododecyl Ether; and mixtures thereof; Neopentyl Glycol Diisononanoate; Cetearyl Ethylhexanoate; Panthenol Ethyl Ether, DL-Panthenol, Hexadecyl N-nonanoate, Hexadecyl N-nonanoate, Fragrance Procurators, Cyclodextrins, Encapsulating Agents, and combinations thereof. Up to 20% by weight of the conditioning agent may be incorporated into the perfumed consumer product, based on the total weight of the perfumed composition.
[0071] It will be appreciated that a person skilled in the art is fully capable of designing the best formulation for the desired effect simply by applying standard knowledge in the field and mixing the above-mentioned components of the perfuming composition by trial and error.
[0072] Besides perfuming compositions comprising at least one compound of formula (I), at least one perfume carrier, at least one perfume base and optionally at least one perfume adjuvant, inventive compositions consisting of at least one compound of formula (I) and at least one perfume carrier are also a particular embodiment of the present invention.
[0073] According to a particular embodiment, the perfuming composition is in the form of microcapsules, preferably in the form of microcapsule slurries, comprising at least one compound of formula (I). In one embodiment, the at least one compound of formula (I) is encapsulated in a core-shell microcapsule, wherein the at least one compound of formula (I) is contained in a core surrounded by a shell. In one embodiment, the shell of the microcapsule protects the compound of formula (I) from environmental influences. The shell is made of a material capable of releasing at least one compound of formula (I). In one embodiment, the shell is made of a material capable of releasing the compound of formula (I) when the shell ruptures and / or by diffusion through the shell. Methods for preparing the microcapsules are well known to those skilled in the art. In addition to the compound of formula (I), the core of the core-shell microcapsule may also comprise at least one liquid carrier as defined above and / or at least one perfuming co-ingredient as defined above. The core-shell microcapsules or core-shell microcapsule slurries comprising at least one compound of formula (I) may be dispersed in at least one liquid carrier as defined above. The liquid carrier may also comprise at least one compound of formula (I) and / or at least one perfuming co-ingredient as defined above.
[0074] According to a particular embodiment, the shell of the microcapsule comprises a material selected from the group consisting of polyureas, polyurethanes, polyamides, polyesters, poly(meth)acrylates (i.e. polyacrylates and / or polymethacrylates), polysiloxanes, polycarbonates, polysulfonamides, polymers of urea and formaldehyde, polymers of melamine and formaldehyde, polymers of melamine and urea, or polymers of melamine and glyoxal, and mixtures thereof. The shell may also be composite, i.e. organic-inorganic, such as a composite shell consisting of at least two types of crosslinked inorganic particles, or a shell resulting from the hydrolysis and condensation reaction of a polyalkoxysilane macromer composition.
[0075] According to a particular embodiment, core-shell microcapsules can also be obtained by using different or more than one encapsulation method.
[0076] In a preferred embodiment, the shells of the microcapsules may each independently be selected from aminoplast, polyamide, polyester, polyurea and polyurethane shells and mixtures thereof.
[0077] In a particular embodiment, the shell of the microcapsules comprises an aminoplast copolymer, such as melamine-formaldehyde or urea-formaldehyde or crosslinked melamine-formaldehyde or melamine-glyoxal.
[0078] In a particular embodiment, the shell of the microcapsule is polyurea-based, made of, for example, but not limited to, isocyanate-based monomers and amine-containing crosslinking agents such as guanidine carbonate and / or guanazole. Certain polyurea microcapsules comprise a polyurea wall, which is a polymeric reaction product between at least one polyisocyanate containing at least two isocyanate functional groups and at least one reactant selected from amines (e.g., water-soluble guanidine salts and guanidine); a colloidal stabilizer or emulsifier; and an encapsulated fragrance. However, the use of amines can be omitted.
[0079] In a specific embodiment, the colloidal stabilizer comprises an aqueous solution of 0.1% to 0.4% polyvinyl alcohol, 0.6% to 1% of a cationic copolymer of vinyl pyrrolidone and quaternized vinyl imidazole (all percentages are defined relative to the total weight of the colloidal stabilizer). In a specific embodiment, the emulsifier is an anionic or amphiphilic biopolymer, which can be selected, for example, from the group consisting of gum arabic, soy protein, gelatin, sodium caseinate, and mixtures thereof.
[0080] In one particular embodiment, the shell of the microcapsule is polyurethane based, made from, for example but not limited to, polyisocyanates and polyols, polyamides, polyesters, and the like.
[0081] In a particular embodiment, the microcapsules have a polymer shell produced by complex coacervation, wherein the shell may be crosslinked.
[0082] In a particular embodiment of the core-shell microcapsules, the core-shell microcapsules comprise an oil-based core comprising a hydrophobic active substance, preferably at least one compound of formula (I), and a composite shell comprising a first material and a second material, wherein the first material and the second material are different, the first material is a coacervate, and the second material is a polymeric material.
[0083] In a specific embodiment, the weight ratio between the first material and the second material is 50:50 to 99.9:0.1.
[0084] In a particular embodiment, the coacervate comprises a first polyelectrolyte, preferably selected from proteins (e.g. gelatin), polypeptides or polysaccharides (e.g. chitosan), most preferably gelatin, and a second polyelectrolyte, preferably alginate, cellulose derivatives, guar gum, pectinate, carrageenan, polyacrylic acid and methacrylic acid or xanthan gum, or a vegetable gum such as gum acacia (gum arabic), most preferably gum arabic.
[0085] The first coacervate material can be hardened chemically using a suitable cross-linking agent such as glutaraldehyde, glyoxal, formaldehyde, tannic acid, or genipin, or can be hardened enzymatically using an enzyme such as transglutaminase.
[0086] The second polymeric material can be selected from the group consisting of polyurea, polyurethane, polyamide, polyester, polyacrylate, polysiloxane, polycarbonate, polysulfonamide, polymers of urea and formaldehyde, polymers of melamine and formaldehyde, polymers of melamine and urea, or polymers of melamine and glyoxal, and mixtures thereof, preferably polyurea and / or polyurethane. The second material is preferably present in an amount of less than 3 wt%, preferably less than 1 wt%, based on the total weight of the microcapsule slurry.
[0087] The preparation of aqueous dispersion / slurry of core-shell microcapsules is well known to those skilled in the art. In a specific embodiment, the microcapsule wall material may include any suitable resin, especially including melamine, glyoxal, polyurea, polyurethane, polyamide, polyester, etc. Suitable resins include the reaction product of aldehydes and amines, and suitable aldehydes include formaldehyde and glyoxal. Suitable amines include melamine, urea, benzoguanamine, glycoluril and their mixtures. Suitable melamines include methylol melamine, methylated methylol melamine, imino melamine and their mixtures. Suitable ureas include dimethylol urea, methylated dimethylol urea, urea-resorcinol and their mixtures. Suitable materials for manufacture can be obtained from one or more of the following companies: Solutia Inc. (St. Louis, Missouri, USA), Cytec Industries (West Patterson, New Jersey, USA), Sigma-Aldrich (St. Louis, Missouri, USA).
[0088] In a specific embodiment of the core-shell microcapsule, the core-shell microcapsule comprises:
[0089] an oil-based core comprising a hydrophobic active substance, preferably at least one compound of formula (I),
[0090] - Optionally, an inner shell made from polymerized multifunctional monomers;
[0091] - A biopolymer shell comprising proteins, wherein at least one of the proteins is cross-linked.
[0092] According to a specific embodiment, the protein is selected from the group consisting of milk protein, caseinate such as sodium caseinate or calcium caseinate, casein, whey protein, hydrolyzed protein, gelatin, gluten, pea protein, soy protein, silk protein and mixtures thereof. Among them, sodium caseinate is preferred, and sodium caseinate is most preferred.
[0093] According to a specific embodiment, the protein comprises sodium caseinate and globular proteins, preferably selected from the group consisting of whey protein, beta-lactoglobulin, ovalbumin, bovine serum albumin, vegetable proteins and mixtures thereof.
[0094] The protein is preferably a mixture of sodium caseinate and whey protein.
[0095] According to a specific embodiment, the biopolymer shell comprises cross-linked proteins selected from the group consisting of sodium caseinate and / or whey proteins.
[0096] According to a particular embodiment, the microcapsule slurry comprises at least one microcapsule made of:
[0097] an oil-based core comprising a hydrophobic active substance, preferably comprising at least one compound of formula (I);
[0098] - an inner shell made from polymerized polyfunctional monomers; preferably a polyisocyanate having at least two isocyanate functional groups;
[0099] - a biopolymer shell comprising proteins, wherein at least one of the proteins is cross-linked; wherein the proteins preferably comprise a mixture comprising sodium caseinate and globular proteins, preferably whey proteins;
[0100] - Optionally, at least one outer mineral layer.
[0101] According to one embodiment, the sodium caseinate and / or whey protein are cross-linked proteins.
[0102] The weight ratio between sodium caseinate and whey protein is preferably from 0.01 to 100, preferably from 0.1 to 10, more preferably from 0.2 to 5.
[0103] In a particular embodiment, the microcapsules are single-shell aminoplast core-shell microcapsules obtainable by a process comprising the steps of:
[0104] 1) mixing a fragrance oil with at least one polyisocyanate having at least two isocyanate functional groups to form an oil phase;
[0105] 2) dispersing or dissolving an aminoplast resin and an optional stabilizer in water to form an aqueous phase;
[0106] 3) preparing an oil-in-water dispersion by mixing an oil phase and an aqueous phase, wherein the average droplet size is 1 to 100 microns;
[0107] 4) performing a curing step to form the wall of the microcapsule; and
[0108] 5) Optionally, the final dispersion is dried to obtain dry core-shell microcapsules.
[0109] In a specific embodiment, the core-shell microcapsules are formaldehyde-free capsules. A typical method for preparing a slurry of aminoplast formaldehyde-free microcapsules comprises the following steps:
[0110] 1) preparing an oligomeric composition comprising the reaction product of, or an oligomeric composition obtained by reacting together:
[0111] a. a polyamine component in the form of melamine or a mixture of melamine and at least one C1-C4 compound comprising two NH2 functional groups;
[0112] b. Glyoxal, C 4-6 The aldehyde component is in the form of a mixture of 2,2-dialkoxyacetaldehyde and optionally glyoxylate, the glyoxal / C 4-6 The molar ratio of 2,2-dialkoxyethanol is 1 / 1 to 10 / 1; and
[0113] c. Protonic acid catalyst;
[0114] 2) preparing an oil-in-water dispersion wherein the droplet size is from 1 to 600 microns and comprising:
[0115] a.Oil;
[0116] b. Water medium
[0117] c. at least one oligomeric composition as obtained in step 1;
[0118] d. at least one cross-linking agent selected from the group consisting of:
[0119] i.C4-C 12 Aromatic or aliphatic di- or triisocyanates and their biuret, triuret, trimer, trimethylolpropane adducts and mixtures thereof; and / or
[0120] ii. a di- or tri-oxirane compound of the formula
[0121] Q-(Oxiran-2-ylmethyl) m
[0122] wherein m represents 2 or 3, Q represents optionally containing 2 to 6 nitrogen and / or
[0123] or a C2-C6 group of an oxygen atom;
[0124] e. Optionally, a C1-C4 compound comprising two NH2 functional groups;
[0125] 3) heating the dispersion;
[0126] 4) Cooling the dispersion.
[0127] The above method is described in more detail in WO 2013 / 068255.
[0128] In a specific embodiment of the core-shell microcapsule, the core-shell microcapsule is a polyamide core-shell polyamide microcapsule comprising:
[0129] an oil-based core comprising a hydrophobic active substance, preferably at least one compound of formula (I), and
[0130] - a polyamide shell comprising or obtainable from:
[0131] ·Acid chloride,
[0132] a first amino compound, and
[0133] A second amino compound.
[0134] According to a particular embodiment, the polyamide core-shell microcapsules comprise:
[0135] an oil-based core comprising a hydrophobic active substance, preferably at least one compound of formula (I), and
[0136] - a polyamide shell comprising or obtainable from:
[0137] Acid chloride, preferably in an amount of 5 to 98%, preferably 20 to 98%, more preferably 30 to 85% w / w;
[0138] The first amino compound is preferably present in an amount of 1% to 50% w / w, preferably 7 to 40%
[0139] w / w;
[0140] The second amino compound is preferably present in an amount of 1% to 50% w / w, preferably 2 to 25%
[0141] w / w;
[0142] • Stabilizer, preferably a biopolymer, preferably in an amount of 0 to 90%, preferably 0.1 to 75%, more preferably 1 to 70%.
[0143] According to a particular embodiment, the polyamide core-shell microcapsules comprise:
[0144] an oil-based core comprising a hydrophobic active substance, preferably at least one compound of formula (I), and
[0145] - a polyamide shell comprising or obtainable from:
[0146] ·Acid chloride,
[0147] a first amino compound, which is an amino acid, preferably selected from the group consisting of L-lysine, L-arginine, L-histidine, L-tryptophan and / or mixtures thereof,
[0148] a second amino compound selected from the group consisting of ethylenediamine, diethylenetriamine, cystamine and / or mixtures thereof, and
[0149] - A biopolymer selected from the group consisting of casein, sodium caseinate, bovine serum albumin, whey protein and / or mixtures thereof.
[0150] The first amino compound may be different from the second amino compound.
[0151] Typically, the method for preparing polyamide-based microcapsules comprises the following steps:
[0152] a) dissolving at least one acid chloride in a hydrophobic material, preferably a fragrance, to form an oil phase;
[0153] b) dispersing the oil phase obtained in step a) into the aqueous phase comprising the first amino compound to form an oil-in-water emulsion;
[0154] c) performing a curing step to form polyamide microcapsules in the form of a slurry;
[0155] wherein a stabilizer is added to the oil phase and / or the water phase, and
[0156] Therein, at least one second amino compound is added to the aqueous phase before forming the oil-in-water emulsion and / or to the oil-in-water emulsion obtained after step b).
[0157] In a particular embodiment, the shell of the microcapsule is polyurea-based or polyurethane-based. Examples of methods for preparing polyurea-based and polyurethane-based microcapsule slurries are described, for example, in WO2007 / 004166, EP2300146, EP2579976. Typically, the method for preparing a polyurea-based or polyurethane-based microcapsule slurry comprises the following steps:
[0158] a) dissolving at least one polyisocyanate having at least two isocyanate groups in oil to form an oil phase;
[0159] b) preparing an aqueous solution of an emulsifier or a colloid stabilizer to form an aqueous phase;
[0160] c) adding the oil phase to the water phase to form an oil-in-water dispersion wherein the average droplet size is from 1 to 500 μm, preferably from 5 to 50 μm; and
[0161] d) applying conditions sufficient to initiate interfacial polymerization and form microcapsules in the form of a slurry.
[0162] In a specific embodiment, the microcapsules can be in powder form, which can be obtained by subjecting the microcapsules slurry to a drying step such as spray drying to provide the microcapsules as is, i.e., in powder form. It should be understood that any standard method for carrying out this drying known to those skilled in the art is also applicable. In particular, the slurry can be spray dried to provide microcapsules in powder form preferably in the presence of a polymeric carrier material such as polyvinyl acetate, polyvinyl alcohol, dextrin, natural or modified starch, gum arabic, vegetable gum, pectin, xanthan gum, alginate, carrageenan or a cellulose derivative.
[0163] However, other drying methods may also be cited, such as extrusion, coating, spray granulation, fluidized bed process, or even drying at room temperature using materials (carrier, desiccant) that meet specific criteria as disclosed in WO2017 / 134179.
[0164] According to a particular embodiment, the above composition comprises more than one compound of formula (I), since it enables the perfumer to prepare blends, fragrances having the odor notes of various compounds of the invention, thereby creating new building blocks for creative purposes.
[0165] For the sake of clarity, it is also understood that any mixture resulting directly from a chemical synthesis in which the compounds of the invention are used as starting material, intermediate or end product, such as a reaction medium without sufficient purification, cannot be considered as a perfuming composition according to the invention, as long as said mixture does not provide the compounds of the invention in a form suitable for use in perfumery. Therefore, unpurified reaction mixtures are generally excluded from the present invention, unless otherwise stated.
[0166] The compounds of the invention can also be advantageously used in all areas of modern perfumery, i.e. fine perfumery or functional perfumery, to actively impart or modify the odor of a consumer product to which said compound of formula (I) is added. Therefore, another object of the present invention is a perfumed consumer product comprising as a perfuming ingredient at least one compound of formula (I) as defined above.
[0167] The compounds of the invention can be added as such or as part of a perfuming composition of the invention.
[0168] For the sake of clarity, a "perfumed consumer product" is a consumer product that provides a pleasant perfuming effect at least to the surface or space to which it is applied, such as the skin, hair, textiles or household surfaces. In other words, a perfumed consumer product according to the invention is a finished product comprising a functional formulation, and optionally additional benefit agents corresponding to the desired consumer product, and an olfactory effective amount of at least one compound of the invention. For the sake of clarity, the perfumed consumer product is a non-edible product.
[0169] The nature and type of ingredients of perfumed consumer products do not warrant a more detailed description here, which is in no way exhaustive, the skilled person being able to choose them on the basis of his general knowledge and according to the characteristics of the product in question and the desired effect.
[0170] Non-limiting examples of suitable perfumed consumer products include perfumes, such as fine perfumes, splashes or eau de perfums, colognes or shaving or aftershave lotions; fabric care products, such as liquid or solid detergents, fabric softeners, liquid or solid fragrance enhancers, dryer sheets, fabric refreshers, ironing water, paper, bleach, carpet cleaners, curtain care products; body care products, such as hair care products (e.g. shampoo, leave-in or rinse-out hair conditioners, coloring preparations or hair sprays, color care products, hair styling products, dental care products), disinfectants, intimate care products; beauty preparations (e.g. skin creams or lotions, vanishing creams or body fragrances (deodorants) or antiperspirants (e.g. sprays or roll-ons)), depilatories, tanning agents, sunscreen or aftersun products, nail products, skin cleansers , cosmetics); or skin care products (e.g. soap, shower or bath mousse, bath oil or shower gel, or hygiene products or foot / hand care products); air care products, such as air fresheners or "ready-to-use" powder air fresheners, which can be used in domestic spaces (rooms, refrigerators, cupboards, shoes or cars) and / or public spaces (lobbies, hotels, shopping malls, etc.); or home care products, such as mildew removers, furniture care agents, wipes, dishwashing detergents or detergents for hard surfaces (e.g. floor, bathroom, sanitary ware or window cleaning); leather care products; car care products, such as polishes, waxes or plastic cleaners.
[0171] According to any embodiment of the invention, the perfumed consumer product of the invention is characterized by a pH of 1 or higher. In particular, the perfumed consumer product of the invention has a pH of 1 to 12, or of 1 to 8. Even more particularly, the perfumed consumer product of the invention has a pH of 1 to 6.
[0172] According to a particular embodiment, the perfumed consumer product of the present invention is in the form of a personal care, home care or fabric care consumer product comprising ingredients commonly found in personal, home or fabric care consumer products, in particular shower gels, shampoos, soaps, fabric detergents or softeners and all-purpose cleaners. The main functional ingredients of perfumed consumer products are surfactants and / or softener ingredients, which are capable of cleaning and / or softening fabrics and / or textiles of various natures, such as clothing, curtain fabrics, carpets and furniture fabrics, etc., or other household surfaces, skin or hair, usually in large amounts of water or in water-based solvents. Therefore, the amount of water in these preparations is usually between 50% and 99% by weight of the perfumed consumer product, with the exception of soaps or solid detergents, in which the amount of water is at most 20%.
[0173] While a more detailed description of such fabric cleaning and / or softening bases is not warranted here, many descriptions of current liquid bases can be found in the patent and other relevant literature on detergents / fabric softeners, such as the textbook "Détergents et Produits de Soins Corporels" by Louis Ho Tan Tai, especially Chapters 1 to 7, Dunod, Paris, 1999, or any other similar and / or more recent textbooks related to the formulation of liquid softeners and multi-purpose cleaners. Patent publication WO 2010 / 105873 is also cited as an example, as it describes typical current ingredients (except perfume) for such liquid products, especially on pages 9 to 21. Of course, many other examples of liquid detergent and / or fabric softener bases can be found in the literature. Any such liquid base, i.e., liquid fabric cleaners or conditioners and / or multi-purpose cleaners, can be used in the compositions described herein.
[0174] According to a particular embodiment of the invention, the perfumed consumer product of the invention is a liquid fabric softener comprising a fabric softener active base in an amount of 85 to 100% by weight, based on the total weight of the perfumed consumer product. The main component of the fabric softener active base is water or a water-based solvent. The fabric softener active base may comprise dialkyl quaternary ammonium salts, dialkyl ester quaternary ammonium salts, Hamburg ester quaternary ammonium salts, triethanolamine quaternary ammonium salts, silicone resins and mixtures thereof. Optionally, the fabric softener active base of the composition may also comprise a viscosity modifier in an amount of 0.05 to 1% by weight, based on the total weight of the liquid base; preferably selected from calcium chloride.
[0175] According to a particular embodiment of the invention, the perfumed consumer product of the invention is a universal cleaner comprising an amount of 85 to 100% by weight of an active base for universal cleaners, based on the total weight of the perfumed consumer product. The main component of the active base for universal cleaners is water or a water-based solvent. The universal active base may comprise linear alkylbenzene sulfonate (LAS) in an amount of 1% to 2%, a nonionic surfactant in an amount of 2% to 4% and an acid, such as citric acid, in an amount of 0.1% to 0.5%.
[0176] According to a particular embodiment of the invention, the perfumed consumer product of the invention is a liquid detergent comprising a liquid detergent active base in an amount of 85 to 100% by weight, based on the total weight of the perfumed consumer product. The main component of the liquid detergent active base is water or a water-based solvent. The liquid detergent active base may comprise an anionic surfactant such as alkylbenzene sulfonate (ABS), linear alkylbenzene sulfonate (LAS), secondary alkyl sulfonate (SAS), primary alcohol sulfate (PAS), lauryl ether sulfate (LES), sodium lauryl ether sulfate (SLES), methyl ester sulfonate (MES), and a nonionic surfactant such as alkylamines, alkanolamides, fatty alcohol poly(ethylene glycol) ethers, fatty alcohol ethoxylates (FAE), ethylene oxide (EO) and propylene oxide (PO) copolymers, amine oxides, alkyl polyglucosides, alkyl polyglucamides; or mixtures thereof.
[0177] According to a particular embodiment of the invention, the perfumed consumer product of the invention is a solid detergent comprising a solid detergent active base in an amount of 85 to 100% by weight, based on the total weight of the perfumed consumer product. The solid detergent active base may comprise at least one surfactant selected from the group consisting of anionic, nonionic, cationic, zwitterionic surfactants and mixtures thereof. The surfactant in the solid detergent active base is preferably selected from the group consisting of linear olefin benzene sulfonates (LABS), sodium laureth sulfate, sodium lauryl ether sulfate (SLES), sodium lauryl sulfate (SLS), alpha-olefin sulfonates (AOS), methyl ester sulfonates (MES), alkyl polyglucosides (APG), primary alcohol ethoxylates, in particular lauryl alcohol ethoxylate (LAE), primary alcohol sulfonates (PAS), soaps and mixtures thereof. The solid detergent active base may contain additional ingredients commonly used in powdered detergent consumer products, selected from the group consisting of: bleaching agents such as TAED (tetraacetylethylenediamine); buffering agents; builders, such as zeolite, sodium carbonate or mixtures thereof; soil release agents or soil suspension polymers; granular enzyme particles, such as cellulase, lipase, protease, mannanase, pectinase or mixtures thereof; corrosion inhibitors; defoamers; suds suppressors; dyes; fillers, such as sodium silicate, sodium sulfate or mixtures thereof; sources of hydrogen peroxide, such as sodium percarbonate or sodium perborate; and mixtures thereof.
[0178] According to a particular embodiment of the invention, the perfumed consumer product of the invention is a shampoo or shower gel comprising a shampoo or shower gel active base in an amount of 85 to 100% by weight, based on the total weight of the perfumed consumer product. The main component of the shampoo or shower gel active base is water or a water-based solvent. The shampoo or shower gel active base may comprise sodium alkyl ether sulfate, ammonium alkyl ether sulfate, alkyl amphoacetate, cocamidopropyl betaine, cocamide MEA, alkyl glucosides and amino acid-based surfactants.
[0179] According to a particular embodiment of the invention, the perfumed consumer product of the invention is a soap bar comprising a soap active base in an amount ranging from 85 to 100% by weight, based on the total weight of the perfumed consumer product. The soap bar active base may comprise a salt of a weak acid, typically a salt of a weak acid (which may be a fatty acid) and a strong base such as sodium hydroxide.
[0180] Some of the above-mentioned perfumed consumer products may represent an aggressive medium for the compounds of the invention and it may therefore be necessary to protect them from premature decomposition, for example by encapsulation or by chemically binding them to another chemical substance suitable for releasing the ingredients of the invention upon exposure to a suitable external stimulus such as enzymes, light, heat or a change in pH.
[0181] The proportions in which the compounds according to the invention can be incorporated into the various products or compositions mentioned above vary within a wide range of values. These values depend on the nature of the article to be perfumed and the organoleptic effect desired, as well as on the nature of the co-ingredients in a given base, when the compounds according to the invention are mixed with perfuming co-ingredients, solvents or additives customary in the art.
[0182] For example, in the case of perfuming compositions, typical concentrations of the compounds of the invention are at levels ranging from 0.001% to 30% by weight, or even more, based on the weight of the perfuming composition into which they are incorporated. In the case of perfumed consumer products, typical concentrations of the compounds of the invention are at levels ranging from 0.0001% to 10% by weight, or even more, based on the weight of the consumer product into which they are incorporated.
[0183] Unless otherwise indicated, all percentages are by weight, based on the total weight of the referenced composition.
[0184] The compounds of the present invention can be prepared according to the methods described below. DETAILED DESCRIPTION
[0185] Example
[0186] The present invention will now be described in further detail by the following examples, wherein abbreviations have their usual meanings in the art and temperatures are expressed in degrees Celsius (°C). 1 H) and 100MHz( 13 C) or a Bruker Avance II Ultrashield 400plus operating at 500 MHz ( 1 H) and 125MHz( 13 C) or a Bruker Avance III 500 operating at 600 MHz ( 1 H) and 150MHz( 13 NMR spectra were obtained using a Bruker Avance III 600 cryoprobe operated at 40 °C. Spectra were internally referenced to 0.0 ppm tetramethylsilane. 1 HNMR signal shifts are expressed in δ ppm, coupling constants (J) are expressed in Hz with the following multiplicities: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; b, broad peak (indicating unresolved coupling) and were interpreted using Bruker Topspin software. 13 CNMR data are presented as chemical shifts in δ ppm and hybridizations from DEPT 90 and DEPT 135 experiments, C, quaternary; CH, methine; CH2, methylene; CH3, methyl.
[0187] Example 1
[0188] Contains 1-(3,3-dimethylcyclopent-1-en-1-yl)ethan-1-ol and 1-(4,4-dimethylcyclopent-1-en-1-yl) Synthesis of mixtures of 1-ethanol
[0189] a) Step 1: Preparation of 3,3-dimethyladipic acid
[0190] A 500mL three-necked round-bottom flask equipped with a magnetic stir bar and a reflux condenser was charged with 230mg of VO3NH4 and 215g of 60% HNO3. The solution was heated to 50°C and 75g of 4,4-dimethylcyclohexanol was carefully added using a syringe pump: First, a few drops of 4,4-dimethylcyclohexanol were added to the pot and the evolution of red gas was observed almost immediately. Once the evolution of red NOx gas was observed, the remaining 4,4-dimethylcyclohexanol was added over 5 hours, during which the temperature rose to 60°C. After the addition was complete, the temperature dropped to 48°C. At this point, the reaction mixture was heated to 90-95°C and maintained for 1 hour to blow off the remaining NOx. The green solution was then allowed to cool slowly to room temperature overnight. The next morning, a white precipitate was observed and the slurry was further cooled to 0°C using an ice bath. The solid was filtered, washed with cold water and then dried at 0.06 mbar / 75°C to give 64.5 g of 3,3-dimethyladipic acid as a white powder (97% purity, silanized with MSTFA). The mother liquor was concentrated to 115 g (from 440 g) on a rotary evaporator and slowly crystallized at room temperature, then cooled in an ice-water bath to give another 9.3 g of a second crop of 3,3-dimethyladipic acid with a purity of 96%. Yield = 70%
[0191] Product 1 H and 13 The C NMR spectrum was consistent with that in the literature (Org. Lett. 2004, 6, 4411-4414).
[0192] b) Step 2: Preparation of 3,3-dimethylcyclopentan-1-one
[0193] A 100 mL cylindrical kuegel-rohr flask was charged with 34.8 g of 3,3-dimethyladipic acid and 1.62 g of Ba(OH)2. Two additional kuegel-rohr balls were connected in series to the cylindrical flask and placed outside the furnace. The apparatus was rotated and the furnace was heated to 270°C at atmospheric pressure under a stream of N2. After reaching 265°C, water vapor, CO2, and another volatile distillate began to collect. After 2.5 hours, the furnace temperature was raised to 275°C and maintained at this temperature for another 6.5 hours until no more distillate was observed. The furnace was cooled, the distillate was phase separated, and the aqueous phase was extracted twice with ether, combined, washed with NaHCO3, and dried over Na2SO4. After removal of the ether, 15.78 g of a clear yellow oil was obtained with a purity of 99%.
[0194] Based on 82% conversion of 3,3-dimethyladipic acid, yield of 3,3-dimethylcyclopentan-1-one = 90%.
[0195] Product 1 H and 13 The C NMR spectrum was consistent with that in the literature (J. Org. Chem. 1996, 61, 8885-8896).
[0196] c) Step 3: Preparation of 1-ethynyl-3,3-dimethylcyclopentan-1-ol
[0197] In a 250 mL three-necked round bottom flask equipped with a magnetic stirring bar and a reflux condenser, 130 mL of a 0.5 M solution of ethynyl-MgBr in THF was charged under N2 and cooled to 2°C. Then 5 g of 3,3-dimethylcyclopentan-1-one was added via a syringe pump over 5 minutes, causing the temperature to rise to 8°C. The reaction was allowed to reach room temperature and stirred for a total of 16.5 hours. The reaction was quenched with 26 g of 10% HCl at 20°C. The phases were separated, and the aqueous phase was extracted 3 times with ether, combined, washed with NaHCO3, dried over Na2SO4 and concentrated on a rotary evaporator, then distilled on a kuegel-rohr (15-10 mbar / 100-150°C) to give 5.1 g of 97% 1-ethynyl-3,3-dimethylcyclopentan-1-ol (yield 84%).
[0198] 1 H-NMR (600MHz, CDCl3): δ (ppm) 1.07 (s, 3H), 1.13 (s, 3H), 1.55-2.18 (m, 7H), 2.49 (s, 1H).
[0199] 13C-NMR (150MHz, CDCl3): δ (ppm) 88.53, 77.23, 77.02, 76.81, 74.93, 70.92, 56.95, 42.46, 39.52, 38.56, 30.76, 30.39.
[0200] d) Step 4: Preparation of a mixture containing 1-(3,3-dimethylcyclopent-1-en-1-yl)ethan-1-one and 1-(4,4-dimethylcyclopent-1-en-1-yl)ethan-1-one
[0201] A 2000mL three-necked flask equipped with a magnetic stirring bar and a reflux condenser was placed under a N2 atmosphere, 375g of 96% H2SO4, 700mL of heptane were added and cooled to -25°C. Using a syringe pump, 87g of 1-ethynyl-3,3-dimethylcyclopentan-1-ol was added over 2.5 hours. During the addition, the temperature changed from -25 to -17°C. After the addition of 1-ethynyl-3,3-dimethylcyclopentan-1-ol, GC analysis of the reaction mixture showed complete conversion. The dark mixture was poured into ice. The aqueous phase was extracted with ether, washed with NaHCO3, dried over Na2SO4 and concentrated on a rotary evaporator to obtain 79.1g of crude concentrate. The latter was then distilled on a short Vigreux column to give 70.3 g of a mixture comprising 1-(3,3-dimethylcyclopent-1-en-1-yl)ethan-1-one (76%) and 1-(4,4-dimethylcyclopent-1-en-1-yl)ethan-1-one (20%), the yield of the mixture of enones 1-(3,3-dimethylcyclopent-1-en-1-yl)ethan-1-one and 1-(4,4-dimethylcyclopent-1-en-1-yl)ethan-1-one being 80%.
[0202] 1 H-NMR (600 MHz, CDCl3): δ (ppm) 1.10 (s, 6H, minor regioisomer), 1.13 (s, 6H, major regioisomer), 1.70 (s, 2H, minor regioisomer), 1.74 (t, 2H, J 6 Hz, major regioisomer), 2.299 (s, 3H, major regioisomer), 2.302 (s, 3H, minor regioisomer), 2.38 (m, 2H, minor regioisomer), 2.56 (triplet of doublet, 2H, J1 6 Hz, J2 1.8 Hz, major regioisomer), 6.45 (t, 1H, J 1.8 Hz, minor regioisomer), 6.62 (bs, 1H, major regioisomer).
[0203] 13C-NMR (150 MHz, CDCl3): δ (ppm), major regioisomer only, 142.8, 153.6, 197.6, 77.2, 77.0, 76.8, 46.4, 38.4, 29.6, 29.5, 27.5.
[0204] e) Step 5: Preparation of a mixture of 1-(3,3-dimethylcyclopent-1-en-1-yl)ethan-1-ol and 1-(4,4-dimethylcyclopent-1-en-1-yl)ethan-1-ol
[0205] A 1000mL three-necked round-bottom flask equipped with a magnetic stirring bar and a reflux condenser was placed under a N2 atmosphere, 9.4g of LiAlH4 was added, and then 500mL of anhydrous ether was added. The slurry was cooled to 4°C, and then a mixture of 1-(3,3-dimethylcyclopent-1-ene-1-yl) 1-ethyl-1-one and 1-(4,4-dimethylcyclopent-1-ene-1-yl) 1-ethyl-1-one prepared in 70g step 4 was added over 2 hours to raise the temperature to a maximum of 7°C. At the end of the introduction, no starting material remained. 9.4mL of H2O was carefully added at 0°C, followed by 9.4mL of 5% NaOH and 28mL of water to quench the reaction. The slurry was stirred until the color became white-gray, and then filtered on a glass frit containing diatomaceous earth. After concentration of the filtrate, 67.8 g of a crude mixture of 1-(3,3-dimethylcyclopent-1-en-1-yl)ethan-1-ol and 1-(4,4-dimethylcyclopent-1-en-1-yl)ethan-1-ol was obtained and used in the next step without further purification.
[0206] Example 2
[0207] Contains 2-(1-(3,3-dimethylcyclopent-1-en-1-yl)ethoxy)-2-methylpropan-1-ol and 2-(1-(4,4- Synthesis of a mixture of dimethylcyclopent-1-en-1-yl)ethoxy)-2-methylpropan-1-ol
[0208] A 25mL three-necked round-bottom flask equipped with a magnetic stirring bar and a reflux condenser was charged with 10g of a mixture of 1-(3,3-dimethylcyclopent-1-ene-1-yl)ethane-1-ol and 1-(4,4-dimethylcyclopent-1-ene-1-yl)ethane-1-ol prepared in Example 1 and 4mL of cyclohexane, and cooled to 0°C under N2. Then 0.12g of BF3OEt2 was added at once, and the temperature was raised to 1.5°C. Then 1.23g of isobutylene oxide dissolved in 0.83g of cyclohexane was added over 3 hours, followed by stirring for another 20 minutes and quenching with NaHCO3. The aqueous phase was extracted 3 times with ether, combined, dried over Na2SO4 and concentrated on a rotary evaporator to give 11.73g of crude product. The crude product was distilled on a Fischer column to give 7.62 g of unreacted 1-(3,3-dimethylcyclopent-1-en-1-yl)ethan-1-ol and 1-(4,4-dimethylcyclopent-1-en-1-yl)ethan-1-ol and 1.49 g of a mixture containing 2-(1-(3,3-dimethylcyclopent-1-en-1-yl)ethoxy)-2-methylpropan-1-ol and 2-(1-(4,4-dimethylcyclopent-1-en-1-yl)ethoxy)-2-methylpropan-1-ol (yield 50%). 1 H-NMR (600 MHz, CDCl3): δ (ppm) major regioisomer only 1.02 (s, 3H), 1.03 (s, 3H), 1.14 (s, 3H), 1.18 (s, 3H), 1.20 (d, 3H, J 6 Hz), 1.68 (t, 1H, J 8 Hz), 2.33 (t, 1H, J 8 Hz), 3.34 (d, 1H, J 13 Hz), 3.40 (d, 1H, J 13 Hz), 4.20 (q, 1H, J 8 Hz), 5.33 (s, 1H).
[0209] 13 C-NMR (150 MHz, CDCl3): δ (ppm), major regioisomer only, 145.6, 135.0, 77.2, 77.0, 76.8, 75.9, 69.9, 66.7, 44.5, 39.2, 30.5, 28.3, 28.2, 23.0, 22.5, 22.4.
[0210] Example 3
[0211] Synthesis and Comparative Examples of Compounds of Formula (I)
[0212] a) Preparation of a composition of matter comprising 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl propionate and 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl propionate (compound of formula (I))
[0213] A 100 mL three-necked round-bottom flask equipped with a magnetic stirring bar and a reflux condenser was charged with 15.4 g of a mixture of 2-(1-(3,3-dimethylcyclopent-1-ene-1-yl)ethoxy)-2-methylpropan-1-ol and 2-(1-(4,4-dimethylcyclopent-1-ene-1-yl)ethoxy)-2-methylpropan-1-ol prepared in Example 2, 0.42 g of DMAP and 50 mL of toluene. The solution was heated to 50 ° C under N2, and then 12.2 g of propionic anhydride was added at one time to raise the reaction temperature to 66 ° C within 5 minutes. The reaction was stirred at this temperature for 1 hour to complete the conversion of the starting material. The reaction mixture was then slowly poured into 128 g of saturated NaHCO3, stirred vigorously for 2 hours, and then transferred to a separatory funnel. The phases were separated (pH 8), the aqueous phase was extracted twice with toluene, combined and concentrated to give 20.51 g of crude concentrate. The latter was distilled on a Kuegel-Rohr to give 20 g of a composition of matter comprising 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl propionate and 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl propionate in a ratio of 83 / 17. Yield = 97%.
[0214] For NMR data see step 5 of example 3b).
[0215] b) Preparation of a composition of matter comprising only 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl propionate (compound of formula (I))
[0216] Step 1 - Preparation of 2,2-dimethyladipaldehyde
[0217] 1.9 g of 2,2-dimethylpent-4-enal prepared according to the method described in Org. Synth. Coll. Vol. 7, 1990, 177 were hydroformylated in an autoclave at 90° C. using 0.015 g of tris(triphenylphosphine)carbonyl hydride rhodium (I), 20 mL of ethyl acetate and 20 bar CO / H2 to give a mixture containing 48% of 2,2-dimethyladipaldehyde (linear product) and 35% of 2,2,4-trimethylglutaraldehyde (branched product). After removal of the solvent, the crude product was chromatographed on silica gel using a pentane / ether gradient of 99 / 1, 95 / 5, 90 / 10, 80 / 20 to 70 / 30, and after bulb-to-bulb distillation of the chromatographic fraction, 1.3 g of 2,2-dimethyladipaldehyde with a purity of 85% were obtained. The product 1 H and 13 The C NMR spectrum was consistent with that in the literature (J. Am. Chem. Soc. 2005, 127, 16778-16779).
[0218] Step 2 - Preparation of 3,3-dimethylcyclopent-1-ene-1-carbaldehyde
[0219] According to the method described in Org. Synth. Coll. Vol. 8, 1993, 208, 0.89 g of crude 3,3-dimethylcyclopent-1-ene-1-carbaldehyde (purity 74%) was prepared using 1.1 g of 2,2-dimethyladipaldehyde and used in the subsequent step without further purification.
[0220] Step 3 - Preparation of 1-(3,3-dimethylcyclopent-1-en-1-yl)ethan-1-ol
[0221] A 25 mL three-necked round bottom flask equipped with a magnetic stir bar and reflux condenser was charged with 2.3 mL of 3MMeMgI and cooled to 0°C under N2 atmosphere. 890 mg of 3,3-dimethylcyclopent-1-ene-1-carbaldehyde (74%) prepared in step 2 (dissolved in about 10 mL of ether) was added to the Grignard reagent in one portion and the pot temperature was raised from 4°C to 15°C. The reaction was allowed to reach 20°C and stirred for a total of 1.5 hours before being quenched with 10% HCl. The crude product was diluted with ether, transferred to a 50 mL separatory funnel, phase separated, extracted twice with ether, washed with NaHCO3, dried over Na2SO4 and concentrated on a rotary evaporator to give 1.1 g of crude yellow oil. The latter was chromatographed on silica gel using 8 / 2 pentane / ether to give 1 g of 1-(3,3-dimethylcyclopent-1-ene-1-yl)ethan-1-ol with a purity of 99%. After bulb-to-bulb distillation, 670 mg of 1-(3,3-dimethylcyclopent-1-en-1-yl)ethan-1-ol with a purity of 99% were obtained.
[0222] 1 H-NMR (600MHz, CDCl3): δ (ppm) 1.038 (s, 3H), 1.044 (s, 3H), 1.29 (d, 3H, J 6.6Hz), 1.70 (t, 2H, J 7.2Hz), 2.35 (t, 2H, J 7.2Hz),4.35(bq,1H),5.35(s,1H).
[0223] 13 C-NMR (150MHz, CDCl3): δ (ppm), 145.4, 134.8, 77.2, 77.0, 76.8, 67.2, 44.6, 39.2, 30.5, 28.37, 28.36, 22.1.
[0224] Step 4 - Preparation of 2-(1-(3,3-dimethylcyclopent-1-en-1-yl)ethoxy)-2-methylpropan-1-ol
[0225] 2-(1-(3,3-dimethylcyclopent-1-en-1-yl)ethoxy)-2-methylpropan-1-ol was prepared according to the procedure described in Example 2 above using neat 1-(3,3-dimethylcyclopent-1-en-1-yl)ethan-1-ol.
[0226] Step 5 - Preparation of 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl propionate
[0227] 2-[1-(3,3-Dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl propanoate was prepared according to the procedure described in Example 3a above using neat 2-(1-(3,3-dimethylcyclopent-1-en-1-yl)ethoxy)-2-methylpropan-1-ol.
[0228] 1 H-NMR (600MHz, CDCl3): δ (ppm) 1.010 (s, 3H), 1.018 (s, 3H), 1.14-1.19 (m, 12H), 1.66 (t, 2H, J 8.6Hz), 2.32 (t, 2H, J 8.6Hz), 2.37 (q, 2H, J 9.1Hz), 3.93(d,1H,J 13.5Hz), 4.01(d,1H,J 13.5Hz), 4.22(q,1H,J 7.7Hz), 5.31(s,1H).
[0229] 13 C-NMR (150MHz, CDCl3): δ (ppm), 174.3, 145.3, 134.8.77.2, 77.0, 76.8, 74.4 ,69.6,67.1,44.5,39.2,30.5,28.3,28.1,27.7,23.7,23.6,22.3,22.1,9.2.
[0230] c) Preparation of 2-(1-(3,3-dimethylcyclopentyl)ethoxy)-2-methylpropyl propionate (comparative compound)
[0231] 2.5 g of 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl propionate prepared in Example 3b were dissolved in 18 mL of THF and 50 mg of 5% Pd / C were added. The mixture was hydrogenated overnight with 1 bar of H2 to completely convert the starting material into a 1 / 1 diastereoisomer mixture of 2-(1-(3,3-dimethylcyclopentyl)ethoxy)-2-methylpropyl propionate. After filtering off the catalyst and removing the THF on a rotary evaporator, 2.51 g of a concentrate were obtained. The latter was distilled on a kuegel-rohr to give 2.5 g of 2-(1-(3,3-dimethylcyclopentyl)ethoxy)-2-methylpropyl propionate (diastereoisomer mixture, purity 99%).
[0232] 1 H-NMR (600 MHz, CDCl3): δ (ppm) diastereoisomer mixture 0.95 (s, 3H), 0.96 (s, 3H), 1.00 (d, 3H, J 2.6 Hz), 1.08 (d, 1H, J 6 Hz), 1.10 (d, 1H, J 6 Hz), 1.19 (s, 6H, J 7.5 Hz), 1.65-1.72 (m, 1H), 1.78-1.84 (m, 1H), 1.97-2.06 (m, 1H), 2.36 (q, 2H, J 7.6 Hz), 3.45 (bdt, 1H), 3.94 (bd, 2H).
[0233] 13 C-NMR (150 MHz, CDCl3): δ (ppm), diastereoisomer mixture, 174.38, 174.37, 77.23, 77.02, 76.81, 73.72, 73.70, 72.2, 72.0, 70.53, 70.49, 46.9, 46.8, 45.001, 44.498, 40.56, 40.45, 38.7, 38.5, 30.3, 30.2, 29.5, 29.25, 29.00, 28.4, 27.7, 24.34, 24.32, 24.30, 23.97, 23.96, 22.0, 21.98, 9.2.
[0234] d) Preparation of a material composition of 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-oxoethyl propionate and 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-oxoethyl propionate
[0235] A 25 mL Schlenk tube equipped with a magnetic stirring bar and a Dean-Stark water separator was charged with 0.5 g of a mixture of 1-(3,3-dimethylcyclopent-1-ene-1-yl) ethyl-1-ol and 1-(4,4-dimethylcyclopent-1-ene-1-yl) ethyl-1-ol prepared in Example 1, 0.49 g of methyl chloroacetate, 0.072 g of dioctyltin oxide and 10 mL of cyclohexane, refluxed for 2 hours, and concentrated with a rotary evaporator to obtain 0.9 g of crude chloroester: 2-chloroacetic acid 1-(3,3-dimethylcyclopent-1-ene-1-yl) ethyl ester and 2-chloroacetic acid 1-(4,4-dimethylcyclopent-1-ene-1-yl) ethyl ester. The latter was redissolved in 10 mL of NMP, 0.5 g of sodium propionate and 0.05 g of NaI were added, and the slurry was stirred at 60° C. for 2 hours until complete conversion. Water was added to dissolve the solid, and the orange mixture was extracted with cyclohexane (3 times) and then with ether (3 times). The combined extracts were washed with NaHCO3, dried over Na2SO4 and concentrated on a rotary evaporator. The crude concentrate was chromatographed on silica gel (60 g, 10 / 1 heptane / EtOAc) to give 0.79 g of a material composition with a purity of 95% containing 2-[1-(3,3-dimethyl-1-cyclopentene-1-yl)ethoxy]-2-oxoethyl propionate and 2-[1-(4,4-dimethyl-1-cyclopentene-1-yl)ethoxy]-2-oxoethyl propionate in a ratio of 75 / 25. The latter was distilled on a kuegel-rohr to give 0.658 g of a transparent white distillate with a purity of 98%. 1 H-NMR (600 MHz, CDCl3): δ (ppm) regioisomer mixture 1.033 (s, 3H), 1.037 (s, 3H), 1.070 (d, 1H), 1.19 (t, 3H, J 7.6 Hz), 1.35 (d, 3H, J 10 Hz), 1.69 (t, 1H, J 7.2 Hz), 2.26-2.36 (m, 1H), 2.45 (q, 2H, J 7.6 Hz), 4.61 (s, 2H), 5.41 (s, 1H, major regioisomer), 5.51 (broad dd, 2H, minor regioisomer).
[0236] 13C-NMR (150 MHz, CDCl3): δ (ppm), regioisomer mixture, 173.78, 173.76, 167.33, 141.59, 140.13, 137.48, 125.72, 77.23, 77.02, 76.81, 70.87, 70.69, 60.76, 60.72, 47.29, 46.58, 44.79, 38.95, 38.52, 30.75, 29.67, 29.64, 28.19, 27.17, 18.99, 18.86, 8.99.
[0237] e) Preparation of 2-(1-(3,3-dimethylcyclopentyl)ethoxy)-2-oxoethyl propionate (comparative compound) composition
[0238] Step 1
[0239] 3.4 g of a mixture containing 1-(3,3-dimethylcyclopent-1-en-1-yl)ethan-1-ol and 1-(4,4-dimethylcyclopent-1-en-1-yl)ethan-1-ol was dissolved in 30 mL of THF and hydrogenated at room temperature with 35 mg of PtO2 as a catalyst under 1 bar of H2. After filtering off the catalyst through a celite bed and removing the solvent, 3.5 g of 1-(3,3-dimethylcyclopentyl)ethan-1-ol with a purity of 95% was obtained, which was directly used in the next step without further purification.
[0240] Step 2
[0241] A 25 mL three-necked round bottom flask equipped with a magnetic stir bar and a Dean-Stark trap was charged with 1.4 g of crude 1-(3,3-dimethylcyclopentyl)ethan-1-ol prepared in step 1, 1.3 g of chloroacetic acid, 0.038 g of pTSA and 10 mL of toluene. The mixture was heated to reflux for 2 hours to completely convert the starting material into two diastereomeric esters of 2-chloroacetic acid 1-(3,3-dimethylcyclopentyl)ethyl ester in a ratio of 48 / 45. The dark brown solution was cooled to 25 ° C and poured into 12 g of saturated NaHCO3, so that the organic phase turned light orange. After stirring the mixture for 5 minutes, the contents were transferred to a separatory funnel and phase separated. The aqueous phase was extracted once with toluene, combined with the remaining organic content and concentrated on a rotary evaporator to give 1.9 g of crude 1-(3,3-dimethylcyclopentyl)ethyl 2-chloroacetate as a 1 / 1 mixture of diastereomers which was used as such in the next step.
[0242] Step 3
[0243] In a 50 mL three-necked round-bottom flask equipped with a magnetic stirring bar and a reflux condenser, 1.8 g of crude 1-(3,3-dimethylcyclopentyl)ethyl 2-chloroacetate prepared in step 2, 15 g of NMP, 1.15 g of sodium propionate and 0.12 g of NaI were placed, stirred at 20 ° C for 64 h and at 75 ° C for 2 hours to completely convert the raw material into 88% of a 1 / 1 diastereomeric mixture of 2-(1-(3,3-dimethylcyclopentyl)ethoxy)-2-oxoethyl propionate. The reaction mixture was cooled to 25 ° C, 15 mL of water was added, and transferred to a separatory funnel. The dark red solution was extracted 5 times with MTBE, the combined extracts (light yellow) were washed twice with 15% NaHSO3 to completely remove the color, then washed with NaHCO3, dried over Na2SO4 and concentrated on a rotary evaporator to give 1.88 g of crude 2-(1-(3,3-dimethylcyclopentyl)ethoxy)-2-oxoethyl propionate. The latter was distilled on a kuegel-rohr to give 0.96 g of 2-(1-(3,3-dimethylcyclopentyl)ethoxy)-2-oxoethyl propionate with a purity of 96% as a 1 / 1 mixture of 2 diastereomers.
[0244] 1 H-NMR (600 MHz, CDCl3): δ (ppm) diastereoisomer mixture 0.96 (s, 3H), 0.97 (s, 3H), 1.01 (s, 3H), 1.02 (s, 3H), 1-17-1.22 (m, 6H), 1.31-1.55 (m, 4H), 1.73-1.82 (m, 1H), 2.16-2.23 (m, 1H), 2.45 (q, 2H, J 7.3 Hz), 4.58 (s, 2H), 4.82-4.89 (m, 1H).
[0245] 13 C-NMR (150 MHz, CDCl3): δ (ppm), diastereoisomer mixture, 173.79, 173.78, 167.72, 167.67, 77.24, 77.03, 76.81, 70.82, 76.34, 76.33, 60.81, 60.80, 44.35, 44.32, 43.94, 43.75, 40.43, 40.27, 39.07, 38.90, 29.83, 29.82, 28.92, 28.81, 27.92, 27.81, 27.18, 18.94, 18.86, 8.98.
[0246] f) Preparation of a composition of matter comprising 2-butenoic acid 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ester and 2-butenoic acid 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ester
[0247] A 25 mL round-bottom flask equipped with a Dean-Stark water separator was charged with 0.7 g of 2-(1-(3,3-dimethylcyclopent-1-ene-1-yl)ethoxy)-2-methylpropan-1-ol and 2-(1-(4,4-dimethylcyclopent-1-ene-1-yl)ethoxy)-2-methylpropan-1-ol prepared in Example 2, 0.7 g of ethyl crotonate, 0.04 g of dibutyltin oxide, and 10 mL of cyclohexane, and heated to reflux under N2 for 18 hours, then cooled to 20° C. The reaction mixture was concentrated on a rotary evaporator to obtain 0.89 g of a crude product. The latter was chromatographed on silica gel using 3 / 1 pentane / ether as solvent to give 0.546 g of a 99% composition of matter containing 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl 2-butenoate and 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl 2-butenoate. After distillation on a kuegel-rohr, 0.529 g of a 99% composition of matter containing 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl 2-butenoate and 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl 2-butenoate was obtained. Yield = 61%.
[0248] 1 H-NMR (600 MHz, CDCl3): δ (ppm) regioisomer mixture 1.00 (s, 3H), 1.01 (s, 3H), 1.19 (d, 1H, J 6.5 Hz), 1.205 (s, 3H), 1.213, (s, 3H), 1.66 (t, 2H, J 7.1 Hz), 1.89 (d, 3H, J 6.8 Hz), 2.32 (t, 2H, J 7.1 Hz), 3.98 (d, 1H, J 11 Hz), 4.05 (d, 1H, J 11 Hz), 4.24 (q, 1H, J 6.4 Hz), 5.30 (s, 1H), 5.88 (d, 1H, J 15.6 Hz), 6.70 (dq, 1H, J1 7 Hz, J2 15.6 Hz).
[0249] 13C-NMR (150 MHz, CDCl3): δ (ppm), regioisomer mixture, 166.39, 145.28, 144.73, 134.81, 122.70, 77.22, 77.02, 76.81, 74.50, 69.65, 67.17, 44.51, 39.20, 30.52, 28.35, 28.18, 23.74, 23.72, 22.34, 17.99.
[0250] g) Preparation of a composition of matter comprising 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl methoxyacetate and 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl methoxyacetate
[0251] A 25 mL Schlenk tube equipped with a Dean-Stark water separator was charged with 0.7 g of 2-(1-(3,3-dimethylcyclopent-1-ene-1-yl)ethoxy)-2-methylpropan-1-ol prepared in Example 2, 2-(1-(4,4-dimethylcyclopent-1-ene-1-yl)ethoxy)-2-methylpropan-1-ol, 1 g of methyl methoxyacetate, 0.04 g of dibutyltin oxide, and 10 mL of cyclohexane, and heated to reflux for 3 hours under N2. The reaction mixture was cooled and concentrated with a rotary evaporator to obtain 1.09 g of concentrate. The concentrate was chromatographed on silica gel using 3 / 1 pentane / ether as solvent to give 0.74 g of a composition of matter comprising 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl methoxyacetate and 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl methoxyacetate, which was distilled on a kuegel-rohr to give 0.73 g of a 99% composition of matter comprising 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl methoxyacetate and 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl methoxyacetate. Yield = 91%.
[0252] 1H-NMR (600 MHz, CDCl3): δ (ppm) regioisomer mixture 1.01 (s, 3H), 1.02 (s, 3H), 1.19 (d, 1H, J 6.5 Hz), 1.20 (s, 6H), 1.66 (t, 2H, J 7.1 Hz), 2.32 (t, 2H, J 6.9 Hz), 3.46 (s, 3H), 4.01 (d, 1H, J 11.2 Hz), 4.07 (s, 2H), 4.10 (d, 1H, J 11.2 Hz), 4.22 (q, 1H, J 6.4 Hz), 5.30 (s, 1H).
[0253] 13 C-NMR (150 MHz, CDCl3): δ (ppm), regioisomer mixture, 170.23, 145.23, 134.91, 77.23, 77.02, 76.81, 74.32, 70.28, 69.73, 67.22, 59.41, 44.53, 39.21, 30.46, 28.33, 28.17, 23.57, 23.49, 22.33.
[0254] h) Preparation of a composition of matter comprising ethyl 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl carbonate and ethyl 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl carbonate
[0255] A 25 mL three-necked round-bottom flask equipped with a reflux condenser was charged with 0.6 g of 2-(1-(3,3-dimethylcyclopent-1-en-1-yl)ethoxy)-2-methylpropan-1-ol and 2-(1-(4,4-dimethylcyclopent-1-en-1-yl)ethoxy)-2-methylpropan-1-ol prepared in Example 2, 0.016 g of DMAP, 0.4 g of triethylamine, 10 mL of toluene, and cooled to 15° C. in a water bath under N2. Then 0.325 mL of ethyl chloroformate was charged to the reaction mixture at once, and the reaction temperature was raised to 20° C. After 1 hour and 45 minutes, 0.8 mL of ethyl chloroformate was added, followed by 0.6 g of triethylamine. The slurry was stirred for a total of 69 hours, then quenched by the addition of 10% HCl, transferred to a 50 mL separatory funnel, extracted with ether, washed with NaHCO3, dried over Na2SO4 and rotary evaporated to give 0.69 g of crude product. The latter was chromatographed on silica gel using 5 / 1 pentane / ether as solvent to give 0.318 g of a composition of matter containing ethyl 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl carbonate and ethyl 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl carbonate at 82%. The chromatographed material was distilled on a kuegel-rohr to give 0.24 g of a 98% composition of matter comprising ethyl 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl carbonate and ethyl 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl carbonate. Yield = 32%.
[0256] 1 H-NMR (600 MHz, CDCl3): δ (ppm) regioisomer mixture 1.01 (s, 3H), 1.02 (s, 3H), 1.19 (d, 1H, J 6.4 Hz), 1.22 (s, 6H), 1.31 (t, 3H, J 7 Hz), 1.66 (t, 2H, J 7.1 Hz), 2.32 (t, 2H, J 7 Hz), 3.96 (d, 1H, J 10.8 Hz), 4.03 (d, 1H, J 10.8 Hz), 4.20 (q, 2H, J 7.3 Hz), 4.25 (q, 1H, J 6 Hz), 5.30 (s, 1H).
[0257] 13C-NMR (150 MHz, CDCl3): δ (ppm), regioisomer mixture, 155.28, 145.30, 134.84, 77.23, 77.02, 76.80, 74.29, 73.48, 67.25, 63.95, 44.51, 39.20, 30.41, 28.31, 28.16, 23.56, 23.48, 22.35, 14.31.
[0258] i) Preparation of a composition of matter comprising 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl (2R)-2-hydroxypropionate and 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl (2R)-2-hydroxypropionate
[0259] A 25 mL three-necked round-bottom flask equipped with a micro Dean-Stark water separator was charged with 0.6 g of 2-(1-(3,3-dimethylcyclopent-1-ene-1-yl)ethoxy)-2-methylpropan-1-ol and 2-(1-(4,4-dimethylcyclopent-1-ene-1-yl)ethoxy)-2-methylpropan-1-ol prepared in Example 2, 0.32 g of ethyl L-lactate, 0.033 g of dibutyltin oxide, and 10 mL of cyclohexane, and heated to reflux under N2. After 40 hours, the reaction was cooled to room temperature. The reaction mixture was cooled and concentrated on a rotary evaporator to obtain 1.11 g of crude product. The latter was chromatographed on silica gel using 2 / 1 pentane / ether as solvent to give 0.4 g of a composition of matter comprising 92% of 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl (2R)-2-hydroxypropionate and 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl (2R)-2-hydroxypropionate. The latter was distilled on a kuegel-rohr to give 0.365 g of distillate containing 98% of a composition of matter comprising 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl (2R)-2-hydroxypropionate and 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl (2R)-2-hydroxypropionate. Yield = 44%.
[0260] 1H-NMR (600 MHz, CDCl3): δ (ppm) isomer mixture 1.01 (s, 3H), 1.02 (s, 3H), 1.18 (d, 1H, J 6.5 Hz), 1.20 (s, 6H), 1.45 (d, 3H, J 6.9 Hz), 1.66 (t, 2H, J 7.4 Hz), 2.32 (t, 2H, J 6.7 Hz), 3.98 (d, 1H, J 11 Hz), 4.04 (d, 1H, J 11 Hz), 4.09 (d, 1H, J 11 Hz), 4.15 (d, 1H, J 11 Hz), 4.22 (bq, 1H,), 4.31 (m, 1H), 5.30 (s, 1H).
[0261] 13 C-NMR (150MHz, CDCl3): δ(ppm), isomer mixture, 175.64, 175.61, 145.19, 145.14, 135.01, 134.97, 122.69, 122.66, 77.23, 77.01, 76.80, 74.31, 74.28, 71.28, 71.25, 70.98, 67.34, 67.33, 67.26, 6 7.24,66.76,66.74,47.31,46.70,46.67,44.534,44.526,39.19,30.47,30.43,29.76,28.31,28.16,23.55,23.52,23.46,23.44,23.42,23.36,22.33,22.32,22.26,22.25,20.41,20.36.
[0262] j) Preparation of a composition of matter comprising 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl (2S)-2-hydroxypropionate and 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl (2S)-2-hydroxypropionate
[0263] Same as Example 3i, except that D-methyllactic acid was used. Yield = 45%.
[0264] 1H-NMR (600 MHz, CDCl3): δ (ppm) isomer mixture 1.01 (s, 3H), 1.02 (s, 3H), 1.18 (d, 1H, J 6.5 Hz), 1.20 (s, 6H), 1.45 (d, 3H, J 6.9 Hz), 1.66 (t, 2H, J 7.4 Hz), 2.32 (t, 2H, J 6.7 Hz), 3.98 (d, 1H, J 11 Hz), 4.04 (d, 1H, J 11 Hz), 4.09 (d, 1H, J 11 Hz), 4.15 (d, 1H, J 11 Hz), 4.22 (bq, 1H,), 4.31 (m, 1H), 5.30 (s, 1H).
[0265] 13 C-NMR (150MHz, CDCl3): δ(ppm), isomer mixture, 175.64, 175.61, 145.19, 145.14, 135.01, 134.97, 122.69, 122.66, 77.23, 77.01, 76.80, 74.31, 74.28, 71.28, 71.25, 70.98, 67.34, 67.33, 67.26, 6 7.24,66.76,66.74,47.31,46.70,46.67,44.534,44.526,39.19,30.47,30.43,29.76,28.31,28.16,23.55,23.52,23.46,23.44,23.42,23.36,22.33,22.32,22.26,22.25,20.41,20.36.
[0266] k) Preparation of a composition of matter comprising 2-oxopropionic acid 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ester and 2-oxopropionic acid 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ester
[0267] A 25 mL three-necked round-bottom flask equipped with a Dean-Stark water trap was charged with 0.7 g of 2-(1-(3,3-dimethylcyclopent-1-en-1-yl)ethoxy)-2-methylpropan-1-ol and 2-(1-(4,4-dimethylcyclopent-1-en-1-yl)ethoxy)-2-methylpropan-1-ol prepared in Example 2, 0.63 g of methyl pyruvate, 0.038 g of dibutyltin oxide, 10 mL of cyclohexane and heated to reflux under N2. After 19 hours, the reaction mixture was cooled and concentrated on a rotary evaporator to obtain 1.06 g of crude concentrate. The latter was chromatographed on an 80 g silica gel column using 3 / 1 pentane / ether as solvent to give 0.458 g of a composition of matter comprising 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl 2-oxopropanoate and 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl 2-oxopropanoate. After distillation on a kuegel-rohr, 0.4 g of a composition of matter comprising 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl 2-oxopropanoate and 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl 2-oxopropanoate was obtained with a purity of 99%. Yield = 62%.
[0268] 1 H-NMR (600 MHz, CDCl3): δ (ppm) regioisomer mixture 1.03 (s, 3H), 1.04 (s, 3H), 1.055 (s, 3H), 1.056 (s, 3H), 1.16 (d, 3H, J 6.4 Hz), 1.62-1.70 (m, 2H), 1.93 (s, 3H), 2.28-2.39 (m, 2H), 3.93 (d, 1H, J 11 Hz), 4.02 (d, 1H, J 11 Hz), 4.08 (q, 1H, J 6.4 Hz), 5.30 (s, 1H).
[0269] 13C-NMR (150 MHz, CDCl3): δ (ppm), regioisomer mixture, 190.91, 161.11, 146.05, 134.94, 128.45, 128.32, 128.20, 128.11, 128.03, 127.95, 127.87, 122.63, 74.14, 74.11, 71.85, 71.79, 67.55, 67.45, 47.60, 46.70, 44.67, 39.52, 30.64, 29.87, 29.81, 28.47, 28.33, 26.18, 26.16, 23.53, 23.43, 23.31, 23.24, 22.64, 22.58.
[0270] l) Preparation of a composition of matter comprising 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ethyl oxalate and 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ethyl oxalate
[0271] A 25 mL three-necked round-bottom flask equipped with a micro Dean-Stark water separator was charged with 0.7 g of 2-(1-(3,3-dimethylcyclopent-1-ene-1-yl)ethoxy)-2-methylpropan-1-ol and 2-(1-(4,4-dimethylcyclopent-1-ene-1-yl)ethoxy)-2-methylpropan-1-ol prepared in Example 2, 0.9 g of ethyl oxalate, 0.037 g of dibutyltin oxide, and 10 mL of cyclohexane, and heated to reflux under N2 for 14.5 h, and then cooled to room temperature. After removing the solvent, 1.47 g of crude product was obtained. The latter was chromatographed on silica gel using 5 / 1 pentane / ether as solvent to give 0.77 g of a mixture containing 10% of ethyl oxalate and 89% of a composition of matter comprising ethyl oxalate 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ester and ethyl oxalate 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ester. The latter was distilled on a kuegel-rohr to give 0.56 g of a distillate containing 99% of a composition of matter comprising ethyl oxalate 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ester and ethyl oxalate 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ester. Yield = 58%.
[0272] 1H-NMR (600 MHz, CDCl3): δ (ppm) regioisomer mixture 1.00 (s, 3H), 1.01 (s, 3H), 1.19 (d, 3H, J 7.8 Hz), 1.25 (s, 6H), 1.38 (t, 3H, J 8.6 Hz), 1.65 (t, 2H, J 8.5 Hz), 2.32 (bq, 2H), 4.11 (d, 1H, J 13.9 Hz), 4.18 (d, 1H, J 13.9 Hz), 4.26 (q, 1H, J 7.7 Hz), 4.36 (q, 2H, J 8.6 Hz), 5.30 (s, 1H).
[0273] 13 C-NMR (150 MHz, CDCl3): δ (ppm), regioisomer mixture, 157.88, 157.73, 145.20, 134.94, 77.27, 77.02, 76.76, 74.15, 72.33, 67.42, 63.03, 44.52, 39.20, 30.36, 28.29, 28.14, 23.63, 23.31, 22.34, 13.94.
[0274] m) Preparation of a composition of matter comprising 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl cyclopropanecarboxylate and 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl cyclopropanecarboxylate
[0275] In a 50mL three-necked round-bottom flask equipped with a magnetic stirring bar and a Dean-Stark water separator, 0.76g of 2-(1-(3,3-dimethylcyclopent-1-ene-1-yl)ethoxy)-2-methylpropan-1-ol and 2-(1-(4,4-dimethylcyclopent-1-ene-1-yl)ethoxy)-2-methylpropan-1-ol prepared in Example 2, 1mL of methyl cyclopropanecarboxylate, 100mg of dibutyltin oxide, and 20mL of cyclohexane were placed and heated to reflux for 18 hours under N2. The reaction mixture was cooled to room temperature and concentrated on a rotary evaporator to obtain 1.5g of crude product. The latter was chromatographed on silica gel using 24 / 1 pentane / ether as solvent to give 0.47 g of a composition of matter comprising 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl cyclopropanecarboxylate and 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl cyclopropanecarboxylate. Yield = 37%.
[0276] 1H-NMR (600 MHz, CDCl3): δ (ppm) regioisomer mixture 0.86 (m, 4H), 1.01 (s, 3H), 1.02 (s, 3H), 1.07 (d, 1H, J 7.8 Hz), 1.19 (s, 3H), 1.19 (s, 3H), 1.20 (s, 3H), 1.62-1.68 (m, 3H), 2.33 (t, 2H, J 7.2 Hz), 3.92 (d, 1H, J 11 Hz), 4.00 (d, 1H, J 11 Hz), 4.23 (q, 1H, J 6.4 Hz), 5.31 (s, 1H).
[0277] 13 C-NMR (150 MHz, CDCl3): δ (ppm), regioisomer mixture, 174.74, 145.30, 134.82, 122.52, 77.23, 77.02, 76.81, 74.45, 69.96, 67.24, 67.15, 47.34, 46.73, 44.52, 39.21, 30.51, 29.78, 28.35, 28.19, 23.69, 23.67, 23.65, 22.33, 12.97, 8.38.
[0278] n) Preparation of a composition of matter comprising ethyl 1-(3,3-dimethyl-1-cyclopenten-1-yl)ethyl malonate and ethyl 1-(4,4-dimethyl-1-cyclopenten-1-yl)ethyl malonate
[0279] A 25 mL Schlenk tube equipped with a Dean-Stark water separator was charged with 0.5 g of a mixture of 1-(3,3-dimethylcyclopent-1-ene-1-yl)ethane-1-ol and 1-(4,4-dimethylcyclopent-1-ene-1-yl)ethane-1-ol prepared in Example 1, 1.6 g of diethyl malonate, 0.042 g of dibutyltin oxide, 5 mL of cyclohexane, heated to reflux for 2.5 hours under N2, then cooled and concentrated on a rotary evaporator. After distillation of the crude concentrate on a kuegel-rohr, 96% 0.52 g of a material composition containing 1-(3,3-dimethyl-1-cyclopentene-1-yl)ethyl malonate and 1-(4,4-dimethyl-1-cyclopentene-1-yl)ethyl malonate was obtained. Yield = 57%.
[0280] 1H-NMR (600 MHz, CDCl3): δ (ppm) regioisomer mixture 1.035 (s, 3H), 1.038 (s, 3H), 1.07 (d, 1H, J 4 Hz), 1.28 (t, 3H, J 7.1 Hz), 1.35 (d, 3H, J 6.5 Hz), 1.69 (t, 1H, J 7.2 Hz), 2.27-2.39 (m, 1H), 3.36 (s, 2H), 4.17-4.24 (m, 2H), 5.41 (s, 1H), 5.49 (q, 1H, J 6.5 Hz).
[0281] 13 C-NMR (150 MHz, CDCl3): δ (ppm), regioisomer mixture, 166.65, 166.64, 165.95, 141.74, 140.26, 137.26, 125.47, 77.25, 77.03, 76.82, 70.85, 70.67, 61.46, 47.31, 46.67, 44.80, 41.98, 41.95, 38.98, 38.52, 30.80, 29.69, 29.65, 28.22, 18.91, 18.80, 14.08.
[0282] o) Preparation of a composition of matter comprising 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl propiolate and 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl propiolate
[0283] In a 50 mL round-bottom flask equipped with a Dean-Stark trap, 2 g of 2-(1-(3,3-dimethylcyclopent-1-en-1-yl)ethoxy)-2-methylpropan-1-ol and 2-(1-(4,4-dimethylcyclopent-1-en-1-yl)ethoxy)-2-methylpropan-1-ol prepared in Example 2, 1.6 g of methyl propiolate, 0.12 g of dibutyltin oxide, and 25 mL of cyclohexane were placed, heated to reflux under N2 for 48 hours, and then cooled to room temperature. After removal of the solvent, the crude product was chromatographed on silica gel using 95 / 5 pentane / ether as solvent to give 1.6 g of a composition of matter comprising 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl propiolate and 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl propiolate. The latter was distilled on a kuegel-rohr to give 1.56 g of a distillate containing 99% of a composition of matter comprising 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl propiolate and 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl propiolate. Yield = 62%.
[0284] 1 H-NMR (600 MHz, CDCl3): δ (ppm) regioisomer mixture 1.01 (s, 3H), 1.02 (s, 3H), 1.19 (d, 3H, J 7.8 Hz), 1.23 (s, 6H), 1.67 (t, 2H, J 7.2 Hz), 2.33 (t, 2H, J 7.1 Hz), 2.89 (s, 1H), 4.03 (d, 1H, J 11 Hz), 4.09 (d, 1H, J 11 Hz), 4.23 (q, 1H, J 6.5 Hz), 5.31 (s, 1H).
[0285] 13 C-NMR (150 MHz, CDCl3): δ (ppm), regioisomer mixture, 152.68, 145.16, 134.96, 77.23, 77.02, 76.81, 74.79, 74.68, 74.09, 71.60, 67.35, 44.52, 39.19, 30.38, 28.31, 28.16, 23.72, 23.36, 22.35.
[0286] p) Preparation of a composition of matter comprising 2-butynoic acid 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ester and 2-butynoic acid 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ester
[0287] In a 50 mL round-bottom flask equipped with a Dean-Stark trap, 2 g of 2-(1-(3,3-dimethylcyclopent-1-en-1-yl)ethoxy)-2-methylpropan-1-ol and 2-(1-(4,4-dimethylcyclopent-1-en-1-yl)ethoxy)-2-methylpropan-1-ol prepared in Example 2, 1.85 g of methyl but-2-ynoate, 0.12 g of dibutyltin oxide, and 25 mL of cyclohexane were placed, heated to reflux under N2 for 24 hours, and then cooled to room temperature. After removal of the solvent, 2.76 g of crude product were obtained, which were chromatographed on silica gel using 95 / 5 pentane / ether as solvent to give 1.59 g of a composition of matter comprising 2-butynoic acid 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ester and 2-butynoic acid 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ester. The latter was distilled on a kuegel-rohr to give 1.55 g of distillate containing 99% of a composition of matter comprising 2-butynoic acid 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ester and 2-butynoic acid 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ester. Yield = 58%.
[0288] 1 H-NMR (600 MHz, CDCl3): δ (ppm) regioisomer mixture 1.01 (s, 3H), 1.02 (s, 3H), 1.19 (d, 3H, J 7.8 Hz), 1.21 (s, 3H), 1.22 (s, 3H), 1.66 (t, 2H, J 8.6 Hz), 1.99 (s, 1H), 2.33 (t, 2H, J 8.5 Hz), 3.99 (d, 1H, J 13 Hz), 4.07 (d, 1H, J 13 Hz), 4.23 (q, 1H, J 7.7 Hz), 5.31 (s, 1H).
[0289] 13 C-NMR (150 MHz, CDCl3): δ (ppm), regioisomer mixture, 153.79, 145.23, 134.89, 85.65, 77.28, 77.02, 76.77, 74.19, 72.45, 71.07, 67.29, 44.51, 39.12, 30.43, 28.32, 28.16, 23.74, 23.58, 23.56, 22.35, 3.82.
[0290] q) Preparation of a composition of matter comprising 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl acrylate and 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl acrylate
[0291] A 50 mL round-bottom flask equipped with a Dean-Stark water trap was charged with 1 g of 2-(1-(3,3-dimethylcyclopent-1-en-1-yl)ethoxy)-2-methylpropan-1-ol and 2-(1-(4,4-dimethylcyclopent-1-en-1-yl)ethoxy)-2-methylpropan-1-ol prepared in Example 2, 0.94 g of ethyl acrylate, 0.059 g of dibutyltin oxide, and 15 mL of cyclohexane, and heated to reflux for 28 hours under N2, and then cooled to room temperature. After removing the solvent, the crude product was chromatographed on silica gel using 95 / 5 pentane / ether as a solvent to obtain 1 g of a material composition containing 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl acrylate and 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl acrylate. The latter was distilled on a Kuegel-Rohr to give 0.92 g of distillate containing 99% of a composition of matter comprising 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl acrylate and 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl acrylate. Yield = 73%.
[0292] 1 H-NMR (600 MHz, CDCl3): δ (ppm): mixture of regioisomers. 1.00(s,3H),1.01(s,3H),1.19(d,3H,J 6.5Hz),1.219(s,3H),1.22(s,3H),1.65(t,2H,J 7.1Hz),2.32(t,2H,J 7Hz),4.01(d,1H,J 11Hz),4.08(d,1H,J 11Hz),4.23(q,1H,J 6.5Hz),5.31(s,1H),5.84(dd,1H,J1 1.3Hz,J2 10.5Hz),6.15(dd,1H,J1 10.5Hz,J2 17.5Hz), 6.42 (dd, 1H, J1 1.3Hz, J210.5Hz).
[0293] 13C-NMR (150 MHz, CDCl3): δ (ppm), regioisomer mixture, 166.05, 145.24, 134.84, 130.72, 128.52, 122.56, 77.23, 77.02, 76.81, 74.43, 70.05, 70.03, 67.28, 67.20, 47.32, 46.71, 44.52, 39.19, 30.48, 29.77, 28.34, 28.17, 23.74, 23.67, 23.63, 22.34, 22.24.
[0294] r) Preparation of a composition of matter comprising butyric acid 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ester and butyric acid 2-[1-(4,4-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl ester
[0295] The preparation was carried out according to the conditions reported in Example 3f), starting from ethyl butyrate and a mixture comprising 2-(1-(3,3-dimethylcyclopent-1-en-1-yl)ethoxy)-2-methylpropan-1-ol and 2-(1-(4,4-dimethylcyclopent-1-en-1-yl)ethoxy)-2-methylpropan-1-ol prepared in Example 2.
[0296] 1 H-NMR (600 MHz, CDCl3): δ (ppm) regioisomer mixture 0.96 (t, 3H, J 7.4 Hz), 1.01 (s, 3H), 1.02 (s, 3H), 1.189 (d, 3H, J 6.5 Hz), 1.19 (s, 3H), 1.20 (s, 3H), 1.64-1.71 (m, 4H), 2.32 (t, 2H, J 7.4 Hz), 3.93 (d, 1H, J 11 Hz), 4.01 (d, 1H, J 11 Hz), 4.23 (q, 1H, J 6.4 Hz), 5.31 (s, 1H).
[0297] 13 C-NMR (150 MHz, CDCl3): δ (ppm), regioisomer mixture, 173.53, 145.31, 134.81, 77.25, 77.04, 76.82, 74.42, 69.87, 67.14, 44.52, 39.22, 36.30, 30.52, 28.35, 28.18, 23.69, 23.59, 22.32, 18.45, 13.74.
[0298] Example 4
[0299] Preparation of perfuming compositions
[0300] A perfuming composition for a fine fragrance is prepared by mixing the following ingredients:
[0301]
[0302]
[0303] *In dipropylene glycol
[0304] 2000 parts by weight of 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl propionate prepared in Example 3b) was added to the above composition, which gave the latter a musky character with a fruity raspberry connotation. The musky character of the composition was detectable after 24 hours. The resulting composition corresponds to the composition according to the invention used in the above examples.
[0305] Addition of the same amount of 2-[1-(3,3-dimethylcyclopentyl)ethoxy]-2-methylpropyl propionate prepared in Example 3c) imparted a lower dusty character than the compound of the invention 2-[1-(3,3-dimethyl-1-cyclopenten-1-yl)ethoxy]-2-methylpropyl propionate, combined with a slight musky connotation. After 24 hours, only the dusty character was perceptible.
[0306] Example 5
[0307] Preparation of an eau de toilette comprising the composition of matter of the present invention
[0308] The eau de toilette was prepared by adding 15 wt % of the composition of the present invention of Example 4 to ethanol, relative to the total weight of the eau de toilette.
[0309] Example 6
[0310] Preparation of liquid detergents containing the compounds of the present invention
[0311] Table 1: Composition of liquid detergent formulations
[0312]
[0313] 1) Hostapur SAS 60; Source: Clariant
[0314] 2) Edenor K 12-18; Source: Cognis
[0315] 3) Genapol LA 070; Source: Clariant
[0316] 4) Source: Genencor International
[0317] 5) Aculyn 88; Source: Dow Chemical
[0318] Liquid detergents were prepared by adding 0.5 to 1.5 wt % of the composition of the present invention of Example 4, relative to the total weight of the liquid detergent, to the unperfumed liquid detergent formula of Table 1 under gentle shaking.
[0319] Example 7
[0320] Preparation of fabric softeners containing the compounds of the invention
[0321] Table 2: Softener formula composition
[0322] Element Concentration [wt%] <![CDATA[Methyl bis[ethyl tallowate]-2-hydroxyethyl methyl sulfate ammonium 1) > 12.20 <![CDATA[1,2-Benzisothiazol-3-one 2) > 0.04 <![CDATA[CaCl2 (10% aqueous solution)]]> 0.40 water 87.36
[0323] 1) Stepantex VL90 A Diester Quat; Source: Stepan
[0324] 2) Proxel GXL; Source: Arch
[0325] The softener is prepared by weighing methylbis[tallowyl]-2-hydroxyethylammonium methyl sulfate heated to 65°C. Water and 1,2-benzisothiazolin-3-one are then placed in a reactor and heated at 65°C with stirring. Methylbis[tallowyl]-2-hydroxyethylammonium methyl sulfate is added to the above mixture. The mixture is stirred for 15 minutes and CaCl2 is added. Then 0.5 to 2 weight % of the composition of the present invention of Example 4 is added relative to the total weight of the softener. The mixture is stirred for 15 minutes and cooled to room temperature with stirring (viscosity measurement: result is 35+ / -5mPas. (shear rate is 10 6 Second -1 )).
[0326] Example 8
[0327] Preparation of a transparent homogeneous shampoo containing the composition of the present invention
[0328] Table 3: Composition of transparent homogeneous shampoo formula
[0329]
[0330]
[0331] 1) Ucare Polymer JR-400, source: Noveon
[0332] 2) Source: Schweizerhall
[0333] 3) Glydant, source: Lonza
[0334] 4) Texapon NSO IS, source: Cognis
[0335] 5) Tego Betain F 50, source: Evonik
[0336] 6)Amphotensid GB 2009, source: Zschimmer&Schwarz
[0337] 7) Monomuls 90L-12, source: Gruenau
[0338] 8) Monosodium paraben, source: NIPA
[0339] The shampoo is prepared by dispersing Polyquaternium-10 in water. The remaining ingredients of Phase A are mixed separately by adding one by one while mixing thoroughly after each adjuvant is added. This premix is added to the Polyquaternium-10 dispersion and mixed for an additional 5 minutes. Then, premixed Phase B and premixed Phase C (Monomuls 90L-12 is heated to melt in Texapon NSO IS) are added while stirring. Phase D and Phase E are added while stirring. The pH is adjusted with citric acid solution until pH: 5.5-6.0 to prepare an unperfumed shampoo formulation.
[0340] Perfumed shampoo is prepared by adding 0.4 to 0.8 wt % of the composition of the invention of Example 4, relative to the total weight of the shampoo, to the unperfumed shampoo formula of Table 3 under gentle shaking.
[0341] Example 9
[0342] Preparation of structured body wash containing the composition of the present invention
[0343] Table 4: Composition of shower gel formula
[0344]
[0345]
[0346] 1) EDETA B powder; Trademark and source: BASF
[0347] 2) CARBOPOL AQUA SF-1 polymer; Trademark and source: NOVEON
[0348] 3) ZETESOL AO 328U; Trademark and source: ZSCHIMMER&SCHWARZ
[0349] 4)TEGO-BETAIN F 50; Trademark and source: GOLDSCHMIDT
[0350] 5) KATHON CG; Trademark and source: ROHM & HASS
[0351] A body wash was prepared by adding 0.5 to 1.5 wt % of the composition of the invention described in Example 4, relative to the total weight of the body wash, to the unperfumed body wash formula of Table 4 under gentle shaking.
[0352] Example 10
[0353] Preparation of a transparent shower gel comprising the composition of the present invention
[0354] Table 5: Composition of the transparent shower gel formula
[0355] Element Concentration (% by weight) Deionized water 52.40 <![CDATA[Sodium EDTA 1) > 0.10 Sodium Benzoate 0.50 Propylene glycol 2.00 <![CDATA[Sodium C12 - C15 alcohol polyether sulfate 2) > 35.00 <![CDATA[Cocamidopropyl betaine 3) > 8.00 <![CDATA[Polyquaternium-7 4) > 0.20 Citric acid (40%) 1.00 Sodium chloride 0.80
[0356] 1) EDETA B powder; Trademark and source: BASF
[0357] 2) ZETESOL AO 328U; Trademark and source: ZSCHIMMER&SCHWARZ
[0358] 3)TEGO-BETAIN F 50; Trademark and source: GOLDSCHMIDT
[0359] 4) MERQUAT 550; Trademark and source: LUBRIZOL
[0360] A clear body wash was prepared by adding 0.5 to 1.5 wt % of the composition of the present invention of Example 4 to the unperfumed body wash formula of Table 5, relative to the total weight of the body wash, under gentle shaking.
[0361] Embodiment 11
[0362] Preparation of a milky shower gel comprising the composition of the present invention
[0363] Table 6: Composition of the emulsion shower gel formula
[0364] Element Concentration (% by weight) Deionized water 50.950 <![CDATA[Sodium EDTA 1) > 0.050 Sodium Benzoate 0.500 Glycerin 86% 3.500 <![CDATA[Sodium Laureth Sulfate 2) > 27.000 <![CDATA[Polyquaternium-7 3) > 1.000 <![CDATA[Coco-Betaine]]> 4) > 6.000 <![CDATA[PEG-120 Methyl Glucose Trioleate 5) > 1.000 Citric acid (40%) 1.000 Glycol Distearate & Laureth-4 & Cocamidopropyl Betaine 6) 3.000 Sodium chloride 20% 5.000 PEG-40 Hydrogenated Castor Oil 7) 1.000
[0365] 1) EDETA B powder; Trademark and source: BASF
[0366] 2)Texapon NSO IS; Trademark and source: COGNIS
[0367] 3) MERQUAT 550; Trademark and source: LUBRIZOL
[0368] 4)DEHYTON AB-30; Trademark and source: COGNIS
[0369] 5) GLUCAMATE LT; Trademark and source: LUBRIZOL
[0370] 6)EUPERLAN PK 3000AM; Trademark and source: COGNIS
[0371] 7) CREMOPHOR RH 40; Trademark and source: BASF
[0372] A clear body wash was prepared by adding 0.5 to 1.5 wt % of the composition of the present invention of Example 4 to the unperfumed body wash formula of Table 6 with gentle shaking, relative to the total weight of the body wash.
[0373] Example 12
[0374] Preparation of pearlescent shampoo containing the composition of the present invention
[0375] Table 7: Composition of pearlescent homogenous shampoo formula
[0376]
[0377] 1) EDETA B powder, source: BASF
[0378] 2) Jaguar C14 S, source: Rhodia
[0379] 3) Ucare Polymer JR-400, source: Noveon
[0380] 4) Sulfetal LA BE, source: Zschimmer&Schwarz
[0381] 5) Zetesol LA, source: Zschimmer & Schwarz
[0382] 6) Tego Betain F 50, source: Evonik
[0383] 7) Xiameter MEM-1691, source: Dow Corning
[0384] 8) Lanette 16, source: BASF
[0385] 9) Comperlan 100, source: Cognis
[0386] 10) Cutina AGS, source: Cognis
[0387] 11) Kathon CG, source: Rohm&Haas
[0388] 12) D-panthenol, source: Roche
[0389] The shampoo is prepared by dispersing guar hydroxypropyltrimonium chloride and polyquaternium-10 in water and tetrasodium EDTA. Once phase A is homogeneous, add NaOH 10% solution (phase B). Then, add premixed phase C. Heat the mixture to 75°C. Add phase D ingredients and mix until homogeneous. Cool the mixture. At 45°C, add phase E ingredients while mixing. Adjust the final viscosity with 25% NaCl solution and adjust pH 5.5-6 with 10% NaOH solution.
[0390] A perfumed pearlescent shampoo is prepared by adding 0.4 to 0.8 wt % of the composition of the invention of Example 4 to the unperfumed shampoo formula of Table 7 with gentle shaking, relative to the total weight of the shampoo.
[0391] Embodiment 13
[0392] Preparation of structured body wash containing the composition of the present invention
[0393] Table 8: Composition of the emulsion shower gel formula
[0394] Element Amount (% by weight) Deionized water 49.350 <![CDATA[Sodium EDTA 1) > 0.050 <![CDATA[Acrylate copolymer 2) > 6.000 <![CDATA[Sodium C12 - C15 alcohol polyether sulfate 3) > 35.000 Sodium hydroxide 20% aqueous solution 1.000 <![CDATA[Cocamidopropyl betaine 4) > 8.000 <![CDATA[Methylchloroisothiazolinone and Methylisothiazolinone 5) > 0.100 Citric acid (40%) 0.500
[0395] 6) EDETA B powder; Trademark and source: BASF
[0396] 7) CARBOPOL AQUA SF-1 polymer; Trademark and source: NOVEON
[0397] 8) ZETESOL AO 328U; Trademark and source: ZSCHIMMER&SCHWARZ
[0398] 9)TEGO-BETAIN F 50; Trademark and source: GOLDSCHMIDT
[0399] 10) KATHON CG; Trademark and source: ROHM & HASS
[0400] A clear body wash was prepared by adding 0.5 to 1.5 wt % of the composition of the present invention of Example 4 to the unperfumed body wash formula of Table 8, relative to the total weight of the body wash, under gentle shaking.
[0401] Embodiment 14
[0402] Preparation of anhydrous antiperspirant spray formulations comprising the composition of the present invention
[0403] Table 9: Composition of anhydrous antiperspirant spray formulations
[0404] Element Amount (% by weight) Cyclomethicone (1) 53.0 Isopropyl myristate 9.0 <![CDATA[Silicon dioxide (2) > 1.0 <![CDATA[Quaternary ammonium salt-18 hectorite (3) > 3.3 <![CDATA[Aluminum Chlorohydrate (4) > 32.7 Fragrance Oil 1
[0405] (1) Dow 345Fluid; Source: Dow Corning
[0406] (2) 200; Source: Evonik
[0407] (3) 38; Source: Elementis Specialities
[0408] (4) Micro Dry Ultrafine; Source: Reheis
[0409] The anhydrous antiperspirant spray formulation was prepared by using a high speed mixer. Silica and quaternium-18-hectorite were added to the mixture of isopropyl myristate and cyclomethicone. Once fully swollen, aluminum chlorohydrate was added in portions under stirring until the mixture was homogeneous and free of lumps. Fragrance oil, i.e., the composition of Example 4 of the present invention, was then added.
[0410] Embodiment 15
[0411] Preparation of a body deodorant spray emulsion formulation comprising the composition of the present invention
[0412] Table 10: Composition of Deodorant Spray Lotion Formulation
[0413] Element Amount (% by weight) Ethanol (95%) 89.25 <![CDATA[Triclosan (1) > 0.25 Isopropyl myristate 9.00 The composition of the present invention of Example 4 1.5
[0414] (1) DP 300; Source: BASF
[0415] (2) A mixture of compound 2a / 2b at a ratio of about 45:55
[0416] The deodorant spray lotion formulation was prepared by mixing and dissolving all ingredients according to the order of Table 10. Fill the aerosol can, compact and add propellant. Aerosol fill: 40% active solution, 60% propane / butane (2.5 bar).
[0417] Example 16
[0418] Preparation of a deodorant stick formulation comprising the composition of the present invention
[0419] Table 11: Composition of Deodorant Stick Formulation
[0420]
[0421] (1) B Power; Source: BASF
[0422] (2) A25; Source: BASF
[0423] (3) APM; Source: Evonik
[0424] (4) DP 300; Source: BASF
[0425] The deodorant stick formulation is obtained by weighing all the components of Part A and heating to 70-75°C. Once the other Part A ingredients are mixed and heated, Ceteareth-25 can be added. Once Ceteareth-25 is dissolved, stearic acid is added. Part B is prepared by dissolving triclosan in 1,2-propylene glycol. Compensate for the evaporated water. Then, slowly pour Part B into Part A while mixing. Add the fragrance oil, the composition of the invention of Example 4 (Phase C), while shaking gently. For storage, place a plastic bag in a bucket and seal it after cooling. Fill the mold at about 70°C.
[0426] Embodiment 17
[0427] Preparation of a roll-on deodorant formulation comprising the composition of the present invention
[0428] Table 12: Composition of Deodorant Roll-On Formula
[0429]
[0430] (1) 250H; Source: Ashland
[0431] (2) DP 300; Source: BASF
[0432] (3) RH 40; Source: BASF
[0433] Part A is prepared by sprinkling hydroxyethylcellulose little by little into water while rapidly stirring with a turbine until the hydroxyethylcellulose is completely swollen and forms a transparent gel. Part B is slowly poured into Part A while continuing to stir until the entire mixture is homogeneous. Parts C and D are then added with gentle shaking.
[0434] Embodiment 18
[0435] Preparation of a day cream base O / W emulsion comprising the composition of the present invention
[0436] Table 13: Composition of Day Cream Base O / W Emulsion Formula
[0437]
[0438] (1) 985; Source: Croda
[0439] (2) 2561; Source: Gattefossé
[0440] (3) Biolip P 90; Source: Gattefossé
[0441] (4) Mineral oil 30-40CPS
[0442] (5) Petroleum jelly
[0443] (6) PO 5; Source: Clariant
[0444] (7) PNC 400
[0445] The day cream base O / W (oil in water) emulsion formulation is prepared by heating phase A and phase B to 70-75°C separately. Phase A is added to phase B and then vacuum is applied. The mixture is stirred and cooled to 55°C for 15 minutes. After cooling to room temperature, phenoxyethanol (and) piroctone olamine (Part C) is added when the temperature reaches 45°C. The mixture is stirred for 5 minutes and then sodium carbomer (Part D) and fragrance oil, which is the composition of the present invention of Example 4 (Part E), are added. The mixture is stirred for 3 minutes and then stirring is stopped for 15 minutes. When the temperature of the mixture reaches 30°C, stirring is continued for another 15 minutes until the cream becomes uniform, glossy and free of lumps. If necessary, the pH value is adjusted to 6.70-7.20 using Glydant, Phenonip or Nipaguard PO5, or to 6.30-7.00 using Nikkoguard.
Claims
1. Use of a compound of formula (I) as a perfuming ingredient, The compound is in the form of any stereoisomer or a mixture thereof, wherein one dotted line represents a carbon-carbon double bond and the other dotted line represents a carbon-carbon single bond; n is 0 or 1; X is a C(=O) or C(Me)2 group; R is a hydrogen atom, C 1-6 Alkyl, C 1-6 Alkoxy, C 2-6 Alkenyl, C 2-6 Alkynyl or C 3-6 Cycloalkyl, C(═O)R′ group or CH(OR″)R″ group, wherein R′ is C 1-3 Alkyl or C 1-3 Alkoxy, and R" are each independently a hydrogen atom or a C 1-3 alkyl.
2. The use according to claim 1, wherein when n is 0, R is C 1-6 Alkoxy.
3. The method according to claim 1, wherein n is 1.
4. The method according to claim 1, wherein the compound of formula (I) is a compound of formula (II), The compound is in the form of any one of its stereoisomers or a mixture thereof, wherein the dashed line and R have the same meanings as defined in claims 1 to 3.
5. The method according to any one of claims 1 to 4, wherein R is C 1-3 Alkyl, C 1-3 Alkoxy, C 2-3 Alkenyl, C 2-3 Alkynyl or C3 cycloalkyl or C(=O)R' group, wherein R' is C 1-2 alkyl.
6. The method according to claim 1, wherein R is ethyl, propyl, ethoxy, prop-1-en-1-yl, 2-ethynyl or cyclopropyl or a C(=O)Me group.
7. The use according to any one of claims 1 to 6, wherein R is ethyl.
8. The use according to any one of claims 1 to 7, wherein the compound of formula (I) is a compound of formula (III), The compound is in the form of any one of its stereoisomers or a mixture thereof.
9. A method of imparting, enhancing, improving or modifying the odor characteristics of a perfuming composition or a perfumed article or surface, which method comprises adding to said composition or article an effective amount of at least one compound of formula (I) as defined in claims 1 to 8.
10. A compound of formula (I) as defined in claims 1 to 8.
11. A perfuming composition comprising: i) at least one compound of formula (I) as defined in claim 10; ii) at least one ingredient selected from the group consisting of a fragrance carrier and a fragrance base; and iii) optionally, at least one flavor adjuvant.
12. A perfumed consumer product comprising at least one compound of formula (I) as defined in claim 10 or a perfuming composition as defined in claim 11.
13. The perfumed consumer product according to claim 12, characterized in that The fragrance consumer product is a perfume, a fabric care product, a body care product, a cosmetic preparation, a skin care product, an air care product or a home care product.
14. The perfumed consumer product according to claim 13, characterized in that The fragrance consumer product is a fine perfume, a perfume or eau de parfum, a cologne, a shaving lotion or aftershave, a liquid or solid detergent, optionally in capsule or tablet form, a fabric softener, a liquid or solid fragrance enhancer, a dryer sheet, a fabric refresher, an ironing water, paper, a bleach, a carpet cleaner, a curtain care product, a shampoo, a leave-in or rinse-off hair conditioner, a coloring preparation, a color care product, a hair styling product, a dental care product, a disinfectant, a private care product, a hair spray, a skin cream or lotion, a vanishing cream, a deodorant or antiperspirant, a depilatory, a tanning agent, a sunscreen or aftersun product, a nail product, a skin cleanser, a make-up product, a soap, a mousse for the shower or bath, a bath oil or shower gel, a foot / hand care product, a hygiene product, an air freshener, a "ready-to-use" powder air freshener, a mildew remover, a furniture care agent, a wipe, a dishwashing detergent or a hard surface detergent, a leather care product, a car care product.
Citation Information
Patent Citations
Esters and their use in perfumery
US20060046955A1
Polyurethane and polyurea microcapsules
WO2007004166A1
Lilial substitute
WO2010105873A2
Stable formaldehyde-free microcapsules
WO2013068255A1
Process for drying a suspension at room temperature
WO2017134179A1
